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GABA and glutamate are two important neurotransmitters present in the central 
nervous system of all vertebrates. Proper functioning of the adult nervous system is 
critically dependent on neurons adopting the correct neurotransmitter phenotype during 
early development. Despite extensive knowledge of the molecular components of these 
two systems, little is known about the mechanisms that generate neuronal diversity, and, 
in particular, how GABAergic and glutamatergic neurons acquire their particular 
phenotype during early development. The purpose of this thesis research was to 
investigate the processes of specification and determination of GABAergic and 
glutamatergic neurons during the early development of Xenopus laevis. There were two 
main objectives: (1) To elucidate the origins of these two kinds of neurons and 
determine whether lineage plays an important role in their determination by constructing 
a fate map for GABAergic and glutamatergic neurons for the Xenopus embryo at the 32- 
cell stage; (2) to determine when cells become specified as GABAergic or glutamatergic 
neurons, thereby testing the hypothesis that the GABAergic system serves as the default 
neurotransmitter phenotype. Our results demonstrate that lineage does not play an 
essential role in the determination of GABAergic and glutamatergic neural phenotypes at 
early cleavage stages. Instead, cell-cell interactions serve as a major determinative 
factor that regulates the adoption of these two phenotypes. Moreover our data suggest 
that both GABAergic and glutamatergic neurons serve as default neurotransmitter 
phenotypes.
SPECIFICATION AND DETERMINATION OF GABAERGIC AND 
GLUTAMATERGIC NEURAL PHENOTYPES IN XENOPUS LAEVIS
CHAPTER I. INTRODUCTION
3Overview of the GABAergic and Glutamatergic Neurotransmitter Systems
The mature vertebrate central nervous system (CNS) is composed of a 
remarkable variety of specialized neurons, all of which are derived from the epithelium of 
the embryonic neural plate. Overall CNS function relies on two major subgroups of 
neurons; those that produce the neurotransmitter GABA and those that produce the 
neurotransmitter glutamate. Gamma-aminobutyric acid (GABA) and glutamate serve as 
two crucial neurotransmitters and are indispensable for the control of normal CNS 
functions. GABAergic neurons are the predominant inhibitory neurons in the CNS of 
vertebrates. In addition, GABA is one of the first neurotransmitters present in the CNS, 
and may exert additional neurotrophic actions during early development (Ben-Ari, 2002). 
Glutamate serves as the major excitatory neurotransmitter, and also functions as an 
amino acid that is essential for normal metabolism. Proper functioning of the adult 
nervous system is critically dependent on neurons adopting the correct neurotransmitter 
phenotype during early development.
In order to transmit neural signals, neurons must express receptors, synthesize 
neurotransmitters, and express the proper transporter proteins to remove excess 
neurotransmitter from the synaptic cleft. In vertebrates, two enzymes that regulate 
GABA synthesis, the glutamic acid decarboxylases GAD67 and GAD65, are expressed 
in GABAergic neurons (Williamson et al., 1995). The action of GABA signaling is 
terminated by its rapid reuptake via membrane-bound GABA transporters (GAT1-4) 
which are present on both pre- and post-synaptic membranes of differentiated neurons 
as well as the surface of glial cells (Minelli et al., 1995; Minelli et al., 1996). Similarly, 
glutamate is rapidly removed from the synaptic space by high-affinity Na+-dependent 
glutamate transporters that are expressed on both glial cells and neurons (Fremeau et 
al., 2004).
4Despite extensive knowledge about the molecular components of these two 
systems, little is known about the mechanisms that generate neuronal diversity, and, in 
particular, how GABAergic and glutamatergic neurons acquire their particular phenotype 
during early development. The purpose of this thesis research was to investigate the 
processes of specification and determination of GABAergic and glutamatergic neurons 
during the early development of Xenopus laevis. There were two main objectives: (1) to 
elucidate the origins of these two kinds of neurons and determine whether lineage plays 
an important role in their determination by constructing a fate map for GABAergic and 
glutamatergic neurons for the Xenopus embryo at the 32-cell stage; (2) to determine 
when cells become specified as GABAergic or glutamatergic neurons, and to test the 
hypothesis that the GABAergic system serves as the default neurotransmitter phenotype.
Review of the Literature 
Neural Induction
The past decade has seen substantial progress in defining the molecular basis of 
initial steps of neural induction. Experiments have demonstrated that bone 
morphogenetic protein (BMP) antagonists secreted from the dorsal lip of the blastopore 
inhibit epidermal development through inactivation of the BMP pathway (Barth et al., 
1999). However, recent work suggests that neural induction commences earlier than 
previously thought and may involve tissues other than the classic organizer region.
These signaling pathways consist of both negative and positive regulators, including the 
Wnts, fibroblast growth factors (FGFs), and Insulin-like growth factors (IGFs), which may 
act upstream of the BMP pathway (Bally-Cuif and Hammerschmidt, 2003; Jessell and 
Sanes, 2000; Kuroda et al., 2004).
5Neural patterning and neurogenesis
Inseparable from neural induction is the regionalization of the nervous system 
along the medial-lateral (the future dorsal-ventral) and the anterior-posterior axes. 
Recent findings have demonstrated that the signaling systems mentioned above 
continue to play a role in subsequent regionalization and patterning, through neighboring 
tissues as well as local organizing centers within the developing nervous system. 
Responses to levels of the BMP, Sonic Hedgehog (Shh), FGF, retinoid and Wnt 
signaling progressively subdivide the future dorsal-ventral (DV) and anterior-posterior 
(AP) axes, leading to the expression of combinations of transcription factors that impart 
a refined regional character to the nervous system (Jessell, 2000; Moens and Prince, 
2002).
Determination of Neural Phenotype
A central and relatively uninvestigated problem in developmental neurobiology is 
how neural progenitors become committed to a specific neurotransmitter phenotype. 
During the development of the central nervous system, many different neurons arise 
from a field of apparently homogenous progenitor cells. These progenitor cells may 
remain totipotent until the time of terminal mitosis (or later) before differentiating 
according to lineage patterns, transcriptional activation, interactions with neighboring 
cells, and/or extracellular cues (Shirasaki and Pfaff, 2002). While the signaling 
molecules and growth factors mentioned above impart positional information, they do not 
alone confer a cellular neurotransmitter identity. Nonetheless, they are intimately 
involved in this process and may bestow a restriction or bias towards a specific 
phenotype. To understand the process of phenotypic determination more fully, it is 
essential to determine when the commitment occurs, which mechanisms impart the 
commitment, and what molecular factors control this commitment. The process of
6neural determination remains poorly understand in vertebrate while many studies have 
address these questions in invertebrate model systems (Brunet and Ghysen, 1999; 
Zhong, 2003), as well as specific vertebrate neuronal phenotypes (e.g. serotonergic), 
much less is known regarding the determination of the GABAergic and glutamatergic 
phenotypes (Hynes and Rosenthal, 1999).
GABAergic and Glutamatergic Phenotype Specification and Determination
The following section will review the literature governing the development of 
GABAergic and glutamatergic neurons.
a) GABAergic and Glutamatergic Cell Fate Determination: Role of Transcription 
Factors
Following neural plate patterning, most neural progenitors are maintained in a 
proliferative state until the specific transcription factors leading to a differentiated 
phenotype are activated. Recent evidence has led to the concept of “selector” genes, a 
class of factors that control the fate of groups of cells during development by activating a 
large number of genes that are expressed in a particular cell type, tissue, or organ, while 
at the same time repressing genes associated with alternate fates (Cheng et al., 2004). 
Expression and mutation analysis have provided important information regarding 
determinative transcription factors.
GABAergic Cell Fate Determination
A number of reports have identified transcription factors that are candidates for 
regulating GABAergic specification. These transcription factors are expressed in regions 
known to contain the progenitors of GABAergic neurons. Certain transcription factors 
containing a basic helix-loop-helix (bHLH) domain, that have been shown to play an 
essential role in determining the specification of GABAergic neurons, are expressed in a
7common GABAergic progenitor before tangential cortical migration. One of these factors, 
Mashl, is predominantly expressed in the ventral telencephalon, which gives rise to both 
GABAergic and cholinergic neurons (Bellion et al., 2003; Parras et al., 2002; Wilson and 
Rubenstein, 2000). In the Mashl knockout mouse model, a decrease in proneural 
transcriptional activation causes a loss of progenitor cells in the ventral telencephalon, 
leading to a loss of GABAergic interneurons in the cortex (Casarosa et al., 1999). 
Members of the Hes family are known to directly repress the transcription of the 
proneural gene Mashl, and recently a novel mouse protein, Heslike, was found to 
regulate the timing of GABAergic neuron formation (Miyoshi et al., 2004).
In addition to repressive factors, a positive element to the regulation of 
GABAergic determination also exists. (Yung et al., 2002) reported that sonic hedgehog 
(Shh) is required for the generation of GABAergic neuronal progenitors in ventral 
forebrain stem cells, due, in part, to activation of Mashl and other bHLH transcription 
factors, Olig2. Depending on the developmental time period, BMP signaling may 
cooperate with Shh to regulate the spatial and temporal aspects of GABAergic neural 
development by altering the transcription factor complement within stage-specific 
progenitors in the cerebral cortex (Gross et al., 1996).
In addition to bHLH genes, the homeodomain genes Nkx2.1, Dlx1/2, and Gsh2 
are reported to be involved in the formation of GABAergic neurons within the 
telencephalon (Bellion et al., 2003; Miyoshi et al., 2004; Parras et al., 2002; Schuurmans 
and Guillemot, 2002; Stuhmer et al., 2002). Other transcription factors presumably 
regulate the specification of GABAergic neurons by controlling the expression of enzyme 
required for GABA biosynthesis. In particular, the overexpression of Dlx2 and Dlx5 have 
been shown to induce the expression of glutamic acid decarboxylases (GADs), the 
family of enzymes that synthesize GABA (Stuhmer et al., 2002).
Glutamatergic Neuronal Determination
In comparison, much less is known about the regulation of glutamatergic neuron 
determination. One of the candidate gene, neurogenin (Ngn), is thought to regulate 
glutamatergic pyramidal neurons in the dorsal telencephalon by limiting the number of 
progenitor cell divisions and initiating a downstream transcriptional cascade that leads to 
a subtype specific developmental program (Parras et al., 2002). BMP ligands also have 
been reported to promote the migration and differentiation of glutamatergic neurons from 
specific cortical progenitor cells (Yung et al., 2002).
In addition, the homeobox genes Tlx1 and Tlx3 may also help specify a subset of 
glutamatergic neurons. These genes serve as post-mitotic selector genes that 
determine excitatory over inhibitory cell fates in the mouse dorsal spinal cord (Cheng et 
al., 2004). In the developing chick spinal cord, Tlx3 expression is sufficient to repress 
endogenous GABAergic differentiation and to induce the formation of glutamatergic cells 
(Logan et al., 1998).
While the above studies implicate important players in GABAergic and 
glutamatergic cell fate specification, there remains no overall understanding of 
GABAergic and glutamatergic neurotransmitter phenotype determination.
b) GABAergic and Glutamatergic Cell Fate Determination: Role of Lineage
As described above, the specification of GABAergic and glutamatergic 
transmitter phenotypes in different areas of the central nervous system is regulated by 
distinct region-specific sets of transcriptional regulators. However, how these regulators 
are localized in different progenitors is not well known. Cell lineage and cell-cell 
interactions may serve as complementary factors, which can localize the transcriptional 
regulators to the proper cell in the embryo.
9Few papers describe the role of lineage in determining GABAergic and 
glutamatergic phenotypes. Huang and Moody (1997), Moody (1999) had reported that 
early lineage is necessary for determination of particular neural subtypes in the retina. 
Although these investigators did not specifically explore the role of lineage in GABAergic 
and glutamatergic fate determination, they showed that lineage imparts a bias on retinal 
progenitors to produce different amacrine phenotypes (Huang and Moody, 1997; Moody, 
1999).
c) GABAergic and Glutamatergic Cell Fate Determination: Role of Growth Factors
A primary mechanism for regulating the differential expression of intrinsic growth 
factors is through cell-cell interactions, which take place by means of extrinsic factors. 
Investigators have proposed that spatially and temporally regulated signals in the 
microenvironment of a nascent cell might determine its fate (Yokoyama et al., 1994). 
These signals in the environment are directly or indirectly derived from other cells, and 
provide proliferating cells with instructions about fate determination.
Diffusible factors, such as Shh and BMPs, play crucial roles in normal pattern 
formation and cellular differentiation, and as mentioned above, are involved in the 
development of GABAergic and glutamatergic neurons. Other signaling molecules 
include fibroblast growth factor 2 (Fgf2) (Korada et al., 2002), brain-derived neurotrophic 
factor (BDNF) (Berninger et al., 1995; Marty et al., 1996a; Marty et al., 1996b; Yamada 
et al., 2002), and basic fibroblast growth factor (bFGF) (Yokoyama et al., 1994).
Knockout experiments have demonstrated that Fgf2 null mice show a 40% decrease in 
the number of cortical glutamatergic pyramidal neurons (Korada et al., 2002). In contrast 
to pyramidal neurons, the abundance of cortical GABAergic interneurons are unaffected 
by the lack of Fgf2. This loss of glutamatergic neurons, coupled with a sparing of 
GABAergic interneurons, suggests that the development of these two cortical neuron
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types is not interdependent, but rather that their development is subject to the influence 
of distinct genetic and environmental factors.
Dissociated cell cultures are often used to test the in vitro effects of potential 
candidate signaling molecules that control cell fate decision. In dissociated hippocampal 
cell cultures, BDNF treatment can induce an increase in GAD levels, as well as an 
increase in the soma size of GABAergic neurons (Yamada et al., 2002). BDNF may also 
exert its function by selectively enhancing the maturation of GABAergic synapses 
(Yamada et al., 2002).
Cell-cell interactions are critical in establishing the spatial organization of different 
cell phenotypes at many points in development. During early embryogenesis, cells 
undergo a series of cell-cell interactions to establish regional fates as well as the overall 
body plan (Gurdon, 1992). It has also been shown that interactions between specific 
cells are required for the terminal differentiation of some cell types later in 
embryogenesis.
Grafting and ablation experiments on the developing spinal cord have 
demonstrated that cell-cell interactions are also important in establishing the spatial 
organization of different neuronal phenotypes (Goulding et al., 1993; Yamada et al., 
1991). Cell culture studies have shown that the presence of a specific neighboring cells 
as well as the duration of the specific cell-cell interactions strongly influences cell 
phenotypes. For example, if post-mitotic chick cells are dissociated from the retina early 
in development, they will differentiate into photoreceptors; however, if they are 
dissociated at a later point, they will differentiate into neurons (Repka and Adler, 1992; 
Yamada et al., 1991). Positive or negative interactions between cells within the 
differentiating neuroepithelium have been shown to work collectively to determine the 
final cell fate. (Tsai and McKay, 2000) have demonstrated that cortical progenitors 
(isolated from the rat embryonic cortex and cultured in monolayers), are more likely to
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form neurons if the cells are plated at low density, suggesting that a contact-mediated 
signaling pathway inhibits neurogenesis.
To date, these investigations have revealed a common principle guiding the 
specification of a cell’s neurotransmitter phenotype: namely, that neurotransmitter 
phenotypes are governed by a combination of intrinsic and extrinsic factors that differ 
depending on a cell’s position along the DV and AP axis. For many cell types these 
combinations remain largely unknown. This is particularly true for GABAergic and 
glutamatergic specification. Arguably, these are the least well-studied neurotransmitter 
phenotypes, and there is no consensus as to how neurons acquire GABAergic or 
glutamatergic neurotransmitter phenotypes throughout the vertebrate nervous system. 
We therefore undertook a series of experiments to begin to address how and when 
neural progenitor cells acquire GABAergic and glutamatergic phenotypes.
Overview of Research Project
a) Xenopus laevis as a Model Organism
The Xenopus model system offers several important advantages to aid in the 
investigation of neural cell fate determination. Each pair of frogs can produce a large 
number of embryos (~1000/mating) that are easily maintained in simple, undefined 
media without serum or growth factors. The embryos are relatively large (~3mm) and 
accessible (due to external fertilization), which allows dissection and intracellular 
injections as well as transgenesis. The locations of early cleavage blastomeres are in a 
predictable pattern and the fates of each blastomere at the 32-cell stage have been 
described in detail. Finally, the embryology and molecular biology of Xenopus are well 
characterized.
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b) Hypothesis and Experiments
In the present study, we began to address the question of how glutamatergic and 
GABAergic neurons acquire their identity. Specifically, we asked two questions. First, 
does early lineage play a role in the determination of neurotransmitter phenotype, as it 
does in the retina? Here, we tested the hypothesis that lineage does not play a 
determinative role in specification but rather may bias phenotypic outcome. Second, in a 
series of primary cell culture experiments we investigated when these phenotypes are 
specified, and tested the hypothesis proposed in the literature that GABAergic neurons 
serve as the default neurotransmitter phenotype.
CHAPTER II: MATERIALS AND METHODS
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Animals
Sexually mature albino Xenopus laevis frogs were purchased from Xenopus I 
(Ann Arbor, Michigan). Adult male and female frogs were isolated for mating 12-14 
hours before the experiments. To stimulate mating behavior, males were injected with 
400 IU of human chorionic gonadotropin (HCG), and females were injected with 600 IU 
of HCG to the dorsal lymph sac. Mating pairs were placed in a plastic mating enclosure 
at 16-19°C, and fertilized embryos were collected in a glass dish every two hours for 8- 
12 hours.
Microsurgery and Cell Culture
The embryos were transferred to freshly prepared dejellying solution (2% L- 
cysteine solution, pH 8.0) and swirled gently for 2-4 minutes until the jelly coats were 
removed. The embryos were then rinsed for two minutes in 100 ml distilled H20, 100 ml 
0.05X modified Barth's saline (MBS; 88 mM NaCI, 1 mM KCI, 0.7 mM CaCI2,10 mM 
MgS04,5 mM HEPES, 2.5 mM NaHC03, pH 7.8) and 100 ml 0.1X MBS in succession. 
After dejellying, embryos were maintained in glass dishes in 0.1 X MBS with 50pg/ml 
gentamycin sulfate (Alexis). Embryos were selected at the desired stages of 
development (Nieuwkoop, 1994) and prepared for dissection. Primary cell cultures were 
prepared essentially as described by (Banker and Goslin, 1991), using embryos at stage 
8 (mid-blastula stage), 10 (early gastrula stage), 12 (mid-gastrula stage), 14 (neural 
plate stage), 16 (mid-neurula stage), 18 (neural tube stage), 20 (late neurula stage) and 
22 (early tailbud stage).
To prevent contamination, all work was performed in a laminar flow hood, and all 
instruments were sterilized with 70% ethanol and exposed to UV light for at least 30 
minutes. The sterilized equipment included the dissection forceps (Dumont No.5), 
plastic culture plates (60 mm Falcon dishes for rinses and washes; 35 mm Nunclon™ A
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dishes for cultures), pipetmen and tip boxes, and the embryo “sterilization sieve” 
apparatus (50 ml Falcon tube with the bottom covered with fiberglass window screen). 
The solutions used in the microsurgery procedure are: calcium- magnesium free (CMF) 
dissociation solution (58.2 mM NaCI, 0.67 mM KCI, 5 mM HEPES, 20U/ml penicillin, 20 
pg/ml streptomycin, pH 7.6); HEPES-buffered Steinberg (HBS) solution (58.2 mM NaCI, 
0.67 mM KCI, 0.34 mM Ca(N03)2, 0.83 mM MgS04, 5mM HEPES, 20U/ml penicillin, 
20pg/ml streptomycin, pH 7.6); and Leibovitz L-15 medium/HBS culture medium (60% 
Leibovitz L-15 (Biowhittaker), 40% HBS solution, 20U/ml penicillin, 20pg/ml streptomycin, 
pH 7.6). These solutions were not sterilized under the UV light. CMF and Leibovitz L-15 
medium/HBS culture medium were filter-sterilized through a 0.22 pm filter system 
(Corning), and HBS solution was sterilized by autoclaving before antibiotics were added.
Embryos at the desired stage were selected and transferred to a fresh 60 mm 
Falcon dish containing fresh HBS and placed under the hood. Embryos were placed in 
“sterilization sieves” and washed with 70% EtOH for about one second, followed by an 
immediate wash in HBS. These washes were repeated three times using fresh HBS 
each time. All dead or lysed embryos were discarded following ethanol washes. To 
remove the vitelline membrane, the embryo was held by a sterile pair of blunt-tips 
forceps. The membrane was then punctured on the ventral side using a pair of sharp-tip 
forceps with and the loosened membrane was peeled off. All of the membrane removal 
and dissection procedures were conducted under a dissecting microscope (Olympus) 
outside of the laminar flow hood. The surviving demembraned embryos were 
transferred to a new 60mm dish filled with fresh HBS for dissection. Briefly, the embryo 
was held by blunt-tip forceps with the dorsal side facing the surface and the anterior end 
toward the top of the dish. The developing presumptive nervous system, along with the 
adjacent epidermis, notochord and myotomes were dissected from the embryo with
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sharp-tip forceps. The neural tissue was then separated from the epidermis, notochord 
and myotomes by incubation with collagenase (Sigma) for 20- 40 minutes. Incubation 
time varied among developmental stages, as tissue attachment is tighter at later stages 
of development. The presumptive neural tissues were incubated with calcium- 
magnesium free dissociation solution for 10-15 minutes. Presumptive neural tissues 
were dissociated by gentle pipetting and plated onto 35 mm culture dishes containing 
Leibovitz L-15 medium/HBS. Dishes were maintained at 20 °C and not disturbed for at 
least 30 minutes. Culture plates were then placed in a dark humidified container at room 
temperature (20-23°C) until sibling embryos reached hatching stage. For fixation, 
culture plates were briefly rinsed in phosphate buffered saline (PBS; 137 mM NaCI, 2.7 
mM KCI, 10 mM Na2HP04, 2mM KH2P04, pH 7.4) and fixed in 
glutaraldehyde/formaldehyde fixative solution (2% sucrose, 40% formaldehyde, 0.02% 
glutaraldehyde, 1X PBS) for 60 minutes at room temperature. The cell cultures were 
then dehydrated by successive five-minute washes in ethanol: 75% PBS/ 25% ethanol, 
50% PBS/ 50% ethanol, 25% PBS/ 75% ethanol. Cell culture plates were stored in 
100% ethanol at -20°C until used for immunocytochemistry or in situ hybridization.
Probe Synthesis
The probes used for in situ hybridization (ISH) procedures were: the antisense 
transcript of the Xenopus GABA transporter 1 cDNA {xGAT1, previously cloned in our 
lab) and a 1650 bp fragment of the Xenopus vesicular glutamate transporter 1 cDNA 
{xVGiut1\ Genebank accession No. AF548627) cDNA. An antisense probe of the 
muscle actin cDNA (Genebank accession No. BC041197) was used as a positive 
procedural control. Negative controls included the sense transcripts of the xGAT1 and 
xVGIutl cDNAs.
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Biorad Mid ip rep
Bacterial stocks containing the xGAT1, xVGIutl, and muscle actin cDNAs were 
obtained from previous lab members. Glycerol stock solutions of xGAT1, xVGIutl or 
muscle actin were added to 50 ml LB cultures containing 50 mg/ml ampicillin; the 
cultures were placed in a horizontal shaker at 37°C for 15-18 hours.
Plasmid DNA for xVGIutl and xGAT1 was isolated by using Biorad Quantum 
Prep plasmid kit according to the manufacturer’s protocol. Overnight cultures were 
centrifuged for five minutes at 5,000 RPM in a Sorvall HB-4 rotor. The supernatant was 
discarded into liquid waste, and five ml of "Cell Resuspension Solution" was added.
After vortexing to resuspend the pellet, five ml of "Cell Lysis Solution" was added and 
mixed well by inversion. Five ml of "Neutralization Solution" was then added to the 
tubes and mixed by inversion. After spinning the tubes for 10 minutes at 8,000 RPM, the 
supernatant was transferred to fresh tubes and one ml of “Quantum Prep Matrix” was 
added. The tubes were then centrifuged for two minutes at 8,000 RPM. Pellets were 
washed in 10 ml of “Wash Buffer” and centrifuged for two minutes at 8,000 RPM. The 
supernatant was discarded into liquid waste and the pellet resuspended in 300 pi of 
"Wash Buffer" by vortexing for 30 seconds. The resuspended pellet mixture was 
transferred to a spin column and centrifuged for 30 seconds at 14,000 RPM. The 
flowthrough from the column was discarded, and the column washed with an additional 
500 pi of wash buffer. Residual wash buffer was removed from the column by spinning 
for two minutes at 14,000 RPM. The column was transferred to a new collection tube 
and the DNA eluted off the column with 300 pi of sterilized distilled water. The eluted 
DNA was stored in collection tubes at 4°C for further use.
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Linearizing Piasmid DNA
Plasmid DNA containing the xGAT1 cDNA was linearized with BamHI and 
transcribed with T7 RNA polymerase to synthesis the antisense probe; Xhol and T3 
RNA polymerase were used to synthesize the sense probe. Plasmid DNA containing a 
1650bp fragment of xVGIutl was linearized with Notl and transcribed with T3 RNA 
polymerase to synthesize an antisense probe; Clal and T7 RNA polymerase were used 
to synthesize the sense probe. Plasmid DNA containing the muscle actin cDNA was 
linearized with EcoRI and transcribed with SP6 RNA polymerase for use as a positive 
control.
To linearize the plasmid DNA, a digestion reaction was set up as follows: 20 pg 
plasmid DNA, 68 pi sterile distilled water, 10 pi of 10X buffer E (Promega; 6 mM Tris-HCI, 
6 mM MgCI2, 100 mM NaCI, 1 mM DTT, pH 7.5) for BamHI, buffer D (6 mM Tris-HCI, 6 
mM MgCI2, 150 mM NaCI, 1 mM DTT, pH 7.9) for Notl and Xhol, buffer C (10 mM Tris- 
HCI, 10mM MgCI2, 50 mM NaCI, 1 mM DTT, pH 7.9) for Clal, and 2 U of the appropriate 
enzyme. The digestion reactions were incubated in a heating block at 37°C for three 
hours. Following digestion, the mixtures were extracted by adding an equal volume of 
phenol/chloroform (P/C) and vortexed for 30 seconds to mix well, before centrifuging for 
five minutes at 14,000 RPM. The P/C layer was withdrawn and the reaction was 
extracted with an equal volume of 24:1 chloroform:isoamyl alcohol (C:IAA). After mixing 
by vortexing for 30 seconds, the tubes were centrifuged for five minutes at 14,000 RPM. 
The aqueous layer was transferred to a new microcentrifuge tube, and 1/10 volume of 
3M NaOAc and two volumes of 100% cold ethanol were added to the tubes. The tubes 
were incubated at -80°C for 30 minutes and then centrifuged at 4°C for 20 minutes at 
14,000 RPM. The supernatant was removed and the pellet was washed in 200 pi 70% 
ethanol, and centrifuged an additional five minutes. The supernatant was discarded and
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the pellet was dried for approximately five minutes in a vacuum concentrator. The pellet 
was resuspended in 20 pi of Tris-EDTA (TE; 1M Tris-HCI, 5M NaCI, pH 7.4) and stored 
at 4°C until further use.
RNA Probe Synthesis
To synthesize RNA probes, 50 pi transcription reactions containing: 1X 
transcription buffer (Promega), 0.01 M DTT, 500 mM each rATP, rCTP, rGTP (Promega), 
325 mM rLITP (Promega), 175 mM digoxigenin-11-uridine-5’ triphosphate (Boehringer 
Mannheim), 3.5 pg linearized DNA template, 10 U ribonuclease inhibitor (Promega), and 
50 U of the appropriate RNA polymerase were mixed and incubated at 37°C. After 30 
minutes, an additional 50 U of the appropriate RNA polymerase was added to the 
reaction mixture and incubated for an additional 30 minutes at 37°C. One unit of RQ1 
RNase-free DNase (Promega) was added to the reaction mixture and incubated for 10 
minutes at 37°C. Fifty pi of TE buffer was added, and the synthesized RNA was 
precipitated by adding 25 pg tRNA (Sigma), 1/10 volume 3M sodium acetate, and two 
volumes 100% cold ethanol. The tube was mixed well and placed at -80°C for 30 
minutes. Following precipitation, the transcription reaction was centrifuged at 14,000 
RPM for 20 minutes at 4°C. The supernatant was discarded and the pellet was dried in 
a vacuum concentrator for approximately five minutes. The dry pellets were 
resuspended in 20 pi TE.
To check the integrity of synthesized probes, an RNA gel containing 0.6 g 
agarose, 1X MOPS buffer (40 mM MOPS, pH 7.5; 50 mM NaCI, 100 mM MgCI2) and 6% 
formaldehyde (Fisher Biotech) was prepared. RNA samples were prepared by adding 3 
jllI of the synthesis reaction, 1.5 p i 10X MOPS, 2  p i 37% formaldehyde, and 5 p i of 
deionized formamide. The RNA probe samples were incubated at 85°C for 10 minutes
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to disrupt secondary structure and subsequently cooled on ice for 10 minutes. Two pi of 
10X formaldehyde gel-loading buffer (50% glycerol, 10mM EDTA, pH 8.0; 0.25% 
bromophenol blue, 0.25% xylene cyanol FF) was added to the samples, and they were 
electrophoresed along with 20 pi 1kB+ DNA ladder (Invitrogen) in 1X MOPS. To 
visualize RNA, the gel was stained in 100 ml sterile distilled water containing 0.1 mg/ml 
ethidium bromide, and destained in distilled water overnight at 4°C. The gel was the 
examined under UV light and photographed with a Polaroid camera. If a probe band 
was present, 300 pi of in situ hybridization buffer (50% formamide, 5X SSC, 1 mg/ml 
Torula RNA, 100 pg/ml heparin, 1X Denhardt's solution, 0.1% CHAPS, 10mM EDTA) 
was added to the RNA probe, and it was stored at -20°C until further use. These probes 
were routinely tested using in situ hybridization on whole mount albino embryos; if the 
signal matched the expected expression pattern, they were used in later experiments.
In situ Hybridization on Primary Cell Cultures
In situ hybridization (ISH) on primary cell cultures was a modification of the 
whole-mount procedures that involved less vigorous washing steps. Cell culture plates 
at the desired stage were rehydrated with five minute washes in graded ethanol as 
follows: 75% ethanol/25% sterile distilled water, 50% ethanol/50% sterile distilled water, 
25% ethanol/75% PTw (1X PBS, 0.1% Tween-20), and 100% PTw. All solutions used in 
this procedure were made with DEPC (diethylpyrocarbonate)-treated water to prevent 
RNase contamination. DEPC-treated water was prepared by adding 100 pi DEPC to 1L 
sterile distilled water, incubating overnight at 37°C, and autoclaving for 20 minutes the 
next day. The plates were washed three times in PBS at room temperature for five 
minutes each. Cell cultures were incubated with one ml triethanolamine (pH 8.0) 
containing 2.5 pi acetic anhydride for 10 minutes. The cells were then permeablized
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with 0.2M HCI for 10 minutes. Following two five minute washes in PBS, cell cultures 
were prehybridized for six hours at room temperature in hybridization buffer. Working 
probe solutions were prepared by adding 900pl hybridization buffer to 100pl stock RNA 
probe solution. Five hundred ju.l probe solution (at a final concentration of 1-2pg/ml) of 
xGAT1, xVGIutl, or muscle actin was added to the dishes and incubated at 60°C for 12- 
15 hours. To prevent the probe solution from evaporating, towels soaked in 50% 
formamide and 5X SSC were placed in the sealed container. The RNA probes were 
collected for reuse after hybridization.
The plates were washed in one ml 0.2X SSC at 60°C for one hour. After the 
cultures cooled to room temperature, a blocking solution consisting of 20% goat serum 
(GibcoBRL) in PBT (1X PBS, 0.1% Triton-100) was added and incubated for one hour at 
room temperature. An anti-digoxgenin antibody (raised in sheep; Roche Diagnostics) 
coupled to alkaline phosphatase was diluted 1:1000 in PBT containing 20% goat serum. 
The culture plates were incubated with this antibody solution overnight at 4°C. To 
remove the excess antibody, cell cultures were rinsed with PBT three times and washed 
four times for 15 minutes each in PBT. For the color reaction, the cell cultures were 
washed twice in alkaline phosphatase (AP) buffer (100mM Tris, pH 9.5; 50mM MgCI2, 
100mM NaCI, 0.1% Tween-20, 1.2mM levimisole) for 10 minutes. The culture plates 
were then incubated in one ml AP buffer containing 4.5pl NBT (Nitro blue tetrazolium, 
75mg/ml in 70% dimethyl formamide) and 3.5fil of BCIP (5-bromo-4-chloro-3-indolyl- 
phosphate, 50mg/ml in 100% dimethyl formamide) until staining was apparent. The 
color reaction was stopped by a one-hour incubation with fresh 1X MEMFA (0.1M MOPS, 
pH 7.4; 2mM EGTA, 1mM MgS04, 3.7% formaldehyde) at room temperature. The 1X 
MEMFA was replaced with 1X PBS for storage prior to data collection.
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Immunocytochemistry on Primary Cell Cultures
To detect neurons using GABA as a neurotransmitter, rabbit polyclonal antibody 
against GABA (Sigma) was used as a primary antibody at an optimal dilution of 1:2500. 
Goat anti-rabbit fragment antibody (Sigma) conjugated to alkaline phosphatase was 
used as the secondary antibody and applied at a concentration of 1:1000. Negative 
controls consisted of incubating cultures in blocking solution in the absence of primary 
antibody prior to secondary antibody incubation. Monoclonal antibody (Sigma) against 
muscle actin was used as a positive procedural control to detect muscle cells present in 
the culture.
Cultures at the desired stages were rehydrated as described previously in the 
ISH procedure. The cell culture plates were washed three times in PBS for five minutes 
each. To reduce background signal, the plates were blocked in 10% (w/v) bovine serum 
albumin (BSA, Fisher) in 1X PBS solution for 60 minutes. The cell cultures were 
incubated with primary rabbit polyclonal antibody against GABA diluted 1:2500 in 3% 
(w/v) BSA overnight at 4°C. To remove excess primary antibody, the cell cultures were 
rinsed three times with Tris-buffered saline (TBS; 10mM Tris, 150mM NaCI, pH 7.4) for 
10 minutes each. The secondary goat anti-rabbit antibody (Sigma) conjugated to 
alkaline phosphatase was diluted 1:1000 in 3% BSA solution and incubated with the 
cultures overnight at 4°C. The culture plates were then washed 12 times with PBS for 
20 minutes each, and the color reaction carried out as described previously for ISH.
After the signal developed, cell cultures were fixed in 1X MEMFA for one hour. The 
MEMFA was then replaced with 1X PBS for storage until data analysis.
Microinjection
Embryos to be used for microinjection were obtained, dejellied, and cultured 
under conditions identical to those used for microsurgery. Microinjection needles made
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from 0.35mm diameter borosilicate (Drummond scientific) glass capillary tubes were 
pulled using a PUL-1 vertical needle puller (World Precision Instrument) with the delay 
setting at three and the heat at nine. The needle tip was broken with forceps, filled with 
heavy mineral oil (Sigma), and mounted into the microinjector. Rhodamine-labeled 
dextran (RLDx; 10K Da MW; Molecular Probes) was the fluorescent tracer used in this 
experiment. RLDx stock powder was resuspended in distilled H20  (Promega) at 2%
(w/v), centrifuged and stored in frozen aliquots. RLDx was diluted to a working 
concentration of 0.5% with distilled H20  and loaded into the needle. The microinjection 
time was set at 100 msec, the pressure at 10 psi, and the volume of each injection was 
2.3 pi. Prior to injection, embryos were placed in a 60mm Falcon dish containing 0.5X 
Marc’s modified Ringer’s (MMR; 0.1M NaCI, 2.0mM KCI, 1mM MgS04, 2mM CaCI2,
5mM HEPES pH 7.8, 0.1 mM EDTA) with 6% ficoll (w/v) for at least 10 minutes.
Regularly cleaving embryos at the 32-cell stage were selected and transferred to small 
wells in a clay dish containing 0.5X MMR with 6% ficoll. Blastomeres of the embryos 
were identified and named according to the nomenclature of (Jacobson and Hirose, 
1981). Blunt-tip forceps were used to angle the embryos so that the desired blastomere 
faced the micropipette. One blastomere of each embryo was injected with RLDx by 
leaving the needle in the cell for three seconds before removal. After all the embryos in 
the dish were injected, they were transferred to a fresh dish containing 0.5X MMR with 
6% ficoll and maintained in this solution for 2-3 hours. Twenty minutes after injection, 
the embryos were observed under the fluorescent microscope to confirm the introduction 
of the tracer into the proper blastomere. Embryos that showed leakage, blebbing, cell 
death, or irregular cleavage were discarded. The embryos were then transferred to 
0.1X MMR with 6% ficoll solution and kept at 16°C overnight. The media was replaced 
with 0.1X MMR the next day. Embryos were cultured until they reached hatching stage 
(stage 32-34), when they were fixed for 1-2 hours in 1X MEMFA. The embryos were
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rinsed in 100% ethanol, and stored at -20°C in fresh 100% ethanol until further 
processing.
Whole-mount In Situ Hybridization
xGAT1 and xVGIutl expression patterns were detected in injected embryos 
using ISH. Muscle actin probes were routinely used with normal non-injected albino 
embryos without RLDx injection as a positive procedural control for ISH. Embryos were 
transferred to five ml DEPC-treated vials (Fisher Scientific) and rehydrated by washing in 
the following solutions for five minutes each: 75% ethanol/25% sterile distilled water,
50% ethanol/50% DEPC-sterile distilled water, 25% ethanol/75% DEPC-PTw, 100% 
DEPC-PTw (3X). All solutions used in this procedure were DEPC treated to prevent 
RNAse contamination. The embryos were then incubated in one ml proteinase K (10 
(ig/ml, Promega) for 30 minutes at room temperature. The embryos were rinsed with 
two 5 minute washes in 0.1M triethanolamine (pH 7-8). Five ml fresh triethanolamine 
was added, along with 12.5pJ acetic anhydride. After a five minute incubation, another 
12.5pl acetic anhydride was added and incubated for an additional five minutes. The 
embryos were then rinsed twice for five minutes in PTw. They were then refixed in 4% 
paraformaldehyde in PTw for 20 minutes and rinsed two times in PTw, five minutes each. 
For prehybridization, one ml of PTw was left in vials and 250pl of hybridization buffer 
added. After the embryos had settled in this solution, it was replaced with 500pl 
hybridization buffer and incubated at 60°C in shaking water bath for 10 minutes. The 
solution was replaced with fresh in situ hybridization buffer and incubated for six hours at 
60°C. After prehybridization, the embryos were incubated in 500pl of xGAT1, xVGlut 1, 
or muscle actin probe solution for 12-16 hours at 60°C. Probes were collected for reuse 
after incubation. The next day, the embryos were incubated in five ml hybridization buffer
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for 10 minutes at 60°C. After removing the buffer, the embryos were washed for 30 
minutes in 2X SSC at 60°C three times. The final wash was replaced with one ml 2X 
SSC containing 20jig/ml RNaseA (Sigma) and incubated for 30 minutes at 37°C. The 
embryos were washed twice in 2X SSC at room temperature for 10 minutes, twice in 
0.2X SSC at 60°C for 30 minutes, and twice in maleic acid buffer (MAB; 100mM maleic 
acid, 150mM NaCI, pH 7.5) for 15 minutes. The embryos were then incubated in MAB 
containing 2% Boehringer Mannheim Blocking (BMB) reagent for one hour at room 
temperature. This solution was replaced with one ml of MAB containing 2% BMB with a 
1:1000 dilution of anti-digoxigenin-AP Fab fragments (Boehringer Mannheim) at 4°C on 
a nutator. To remove the excess antibody, the embryos were washed five times in MAB 
at room temperature for one hour each.
For the color reaction, the embryos were washed twice in AP buffer for five 
minutes each. The embryos were then incubated in one ml AP buffer containing 4.5fil 
NBT and 3.5pil of BCIP until staining was apparent. The color reaction was stopped by 
replacing the solution with 1X MEMFA and incubating overnight at 4°C. MEMFA was 
replaced with 1X PBS the next day for storage prior to analysis.
Two-color In Situ Hybridization
To detect if xGAT1- and xVGIut1-expressing neurons co-localize in the same 
region, two-color in situ hybridization on whole-mount albino embryos was performed. 
The two-color in situ hybridization procedure was similar to conventional ISH, except that 
the fluor-UTP xGAT1 probe and dig-UTP xVGIutl probe were added simultaneously to 
the embryos during the hybridization step.
After blocking the embryos with MAB containing 2% BMB, they were incubated in 
one ml of MAB containing 2% BMB with a 1:1000 dilution of anti-digoxigenin AP Fab
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Frag, antibody overnight at 4°C. The embryos were washed five times in MAB at room 
temperature for one hour each the following day.
The embryos were incubated in AP buffer two times for five minutes each before 
the color reaction. Seven p! of 25 mg/ml magenta phosphate (Biosynth) was added to 
each ml of AP buffer and embryos were incubated at 37°C until signal developed. The 
color reaction was stopped by incubating the embryos in five ml MAB containing 10mM 
EDTA at 65°C for 10 minutes. The embryos were then fixed in 1X MEMFA overnight at 
4°C. After placing the embryos in 2% BMB in MAB for one hour at room temperature, 
they were incubated in MAB containing 2% BMB with a 1:1000 dilution of anti­
fluorescein antibody overnight at 4°C. The second color reaction was carried out after 
washing the embryos five times in MAB for one hour each, and twice in AP buffer for five 
minutes. AP buffer containing 4.5 jul of BCIP per ml was added to the vial, and the 
embryos were incubated in this solution until color developed. The embryos were fixed in 
1X MEMFA overnight at 4°C and placed in 1X PBS for storage.
Paraffin Histology
Following ISH, embryos were embedded in paraffin, sectioned transversely, and 
analyzed for colocalization of RLDx with xGAT1 or xVGIult.
For histological analysis, the embryos were incubated in PBS for 10 minutes, and 
dehydrated with 15-minute washes in the following solutions: 25% ethanol/75% PBS,
50% ethanol/50% PBS, 75% ethanol/25% PBS, 100% ethanol. All washes were five ml 
and carried out at room temperature on a nutator. The embryos were then incubated 
with 15-minute washes in 50% EtOH/50% xylene and 100% xylene at room temperature. 
The embryos were placed into plastic embedding molds with a transfer pipette. The 
molds were filled with 50% xylene/50% paraffin and incubated at 60°C for 20 minutes.
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The xylene and paraffin mixture was then replaced with fresh paraffin and incubated two 
times at 60°C for 90 minutes each. The embryos in each mold were embedded using a 
dissection probe to orient the embryo head-down.
After the paraffin solidified, the embryos were cut into 10 pm sections on a 
microtome (American Optical Company). Microscope slides used for sectioning were 
prepared by treatment with Meyer's albumin fixative (egg white containing a 1:100 ratio 
of 50% glycerol/50% formaldehyde) and dried by heating on a hot plate for 10 seconds. 
Cut sections were floated on a slide covered in the water, and allowed to dry on a 45°C 
slide warmer overnight. The slides were cleared with Citrisolv™ (Fisher) and 
coverslipped with 100% permount (Fisher Scientific) for bright-field and fluorescence 
microscopy.
Data Collection and Histology analysis
To visualize immunocytochemistry and in situ hybridization on cell cultures, as 
well as co-localization of RLDx-ISH signals in tissue sections, an Olympus IX50 inverted 
objective microscope with phase and bright-field optics was used. To observe RLDx- 
labeled embryos, an Olympus SZH10 stereo dissecting microscope was used. RLDx 
fluorescence was visualized using a filter cube with an excitation range of 510-550nm.
All photographs were acquired using an Evolution MP color high resolution digital 
camera (Media Cybernetics).
All specimens were examined at 40x or 100x. Those embryos showing strong 
RLDx fluorescence and robust in situ hybridization signals were examined for areas 
demonstrating co-localization of RLDx and xGAT1 or xVGIutl. For xGAT1, the specific 
structures analyzed for each embryo were the forebrain, midbrain, hindbrain and spinal 
cord. For xVGIutl, five specific structures were observed: pineal gland, cranial nerves
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(V, trigeminal; VII, facials; VIII, acousticus; IX, glossopharyngeal), olfactory placodes, 
brain (forebrain, midbrain, and hindbrain) and spinal cord. The notochord and lens were 
examined in all embryos and used for comparison with previously constructed fate maps 
(Moody, 1987). At least five hatching stage embryos were analyzed for xGAT1 and 




To determine the importance of early lineage in GABAergic and glutamatergic 
neural fate determination, we mapped the spatial distribution and clonal origin of these 
two kinds of neurons in the CNS of Xenopus laevis. Fluorescent tracer was injected into 
each blastomere of a 32-cell stage embryo. GABAergic and glutamatergic neurons were 
detected using xGAT1 and xVGIutl antisense RNA probes for in situ hybridization on 
embryos fixed at hatching stage.
Expression Pattern Analysis
a. xGAT1 mRNA Expression Pattern Analysis
Neurons staining positively for xGAT1 mRNA expression are widely distributed 
throughout the central nervous system by stage 35; signal was observed in the forebrain, 
midbrain, hindbrain, and in bilateral clusters in the spinal cord (Fig. 1 A). In order to 
obtain better resolution of this expression pattern, embryos were subjected to 
histological analysis. Sections demonstrate that xGAT1 mRNA expression is found in 
discrete regions of the forebrain, midbrain, hindbrain, and spinal cord at hatching stage 
(Fig. 1B-E).
In the forebrain, xGAT1 expression is located predominantly in the medial-ventral 
region (Fig. 1B). xGAT1-positive neurons are more intensely stained in the midbrain 
region than neurons located in the forebrain, and the signal was again localized to the 
medial-ventral region (Fig. 1C). Staining is located more dorsally in the hindbrain 
compared with the midbrain (Fig. 1D). Fewer numbers of xGAT1-positive neurons are 
found in the spinal cord. These are less intensely stained relative to the brain and form 
bilateral columns down the length of the spinal cord (Fig. 1E).
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Figure 1. Spatial analysis of xGAT1 mRNA expression in the Xenopus embryo. (A)
Representative whole-mount in situ hybridization of a stage 35 embryo using a 
digoxigenin-labeled xGAT1 antisense probe showing a distinct expression pattern in the 
central nervous system. The observed expression pattern was further examined by 
histological analysis of embryos at the level of the (B) forebrain, (C) midbrain, (D) 
hindbrain, and (E) spinal cord. Arrows indicate xGAT1 specific signal, e, eye; fb, 
forebrain; hb, hindbrain; mb, midbrain; no, notochord; nt, neural tube; ot, otic vesicle; sc, 
spinal cord; so, somite. Dorsal side of the embryo is always at the top of the pictures.
e CQ
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b. xVGIutl mRNA Expression Pattern Analysis
Based on xVGIutl mRNA expression in whole-mount embryos, glutamatergic 
neurons are concentrated in the ventral-lateral region of the central nervous system, 
olfactory placodes, pineal gland, retina and cranial nerves (Fig. 2A). To characterize this 
expression pattern with greater resolution, histological sections of these embryos were 
analyzed (Fig. 2B-G).
In the forebrain, xVGIutl-positive neurons are present in the peripheral dorsal- 
medial region of the neural tube. At the region along the dorsal-ventral axis, staining is 
present in the olfactory placodes, which reside on the both sides of neural tube (Fig. 2B). 
Slightly posterior to these structures, xVGIutl expression is also observed in the pineal 
gland (Fig. 2C). In the midbrain, xVGIutl signal is present in a more ventral region of 
neural tube and staining in the innermost layer of retina is observed at the same level 
(Fig. 2D). Posterior to the midbrain, xVGIutl mRNA expression is observed in cranial 
nerve V (trigeminal) and VII (facial) (Fig. 2E). In the hindbrain, xVGIutl-positive neurons 
are present in cranial nerve VIII (acousticus), IX (glossopharyngeal) and the medial- 
ventral region of the neural tube (Fig. 2F). Throughout the brain, glutamatergic neurons 
are consistently localized to the peripheral (postmitotic) regions of neural tube. Lower 
densities of xVGMf-positive signal are found on the periphery of the neural tube along 
the entire dorsal-ventral axis of the spinal cord (Fig. 2G).
The expression patterns of xGAT1 and xVGIutl reported here are consistent with 
previous findings in whole-mount embryos (Gleason et al., 2003; Hoke, 2000).
c. Coexpression ofxGATI and xVGIutl mRNA
To examine whether GABAergic and glutamatergic neurons are expressed in 
similar regions of the nervous system, two-color in situ hybridization using xGAT1 and 
xVGIutl antisense mRNA probes was conducted on whole-mount embryos (Fig. 3A).
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Figure 2. Spatial analysis of xVGIutl mRNA expression in the Xenopus embryo. (A)
Representative whole-mount in situ hybridization of a stage 34 embryo using a xVGIutl 
antisense probe showing a distinct expression pattern in the central nervous system.
For greater resolution, embryos were subjected to histological analysis at the level of the 
(B,C) forebrain, (D,E) midbrain, (F) hindbrain, or (G) spinal cord. Arrows indicate 
xVGIutl specific staining, cranial nerves: V (trigeminal), VII (facialis), VIII (acousticus),
IX (glossopharyngeal); e, eye; fb, forebrain; hb, hindbrain; mb, midbrain; no, notochord; 
ol, olfactory placodes; ot, otic vesicle; pg, pineal gland; ret, retina; sc, spinal cord; so, 






Figure 3. Comparison of xGAT1 and xVGIutl expression in the developing 
Xenopus embryo. (A) Representative whole-mount two-color in situ hybridization using 
xGAT1 and xVGIutl antisense RNA probes to compare the two expression patterns in 
the hatching stage embryo. xGAT1 expression is stained blue, while the xVGIutl signal 
is magenta. To analyze these expression patterns further, embryos were processed for 
histological analysis at the level of the (B,F) forebrain, (C,G) midbrain, (D,H) hindbrain, 
or (E,l) spinal cord. Panels (F-l) are the sections directly above each (B-E) at higher 
magnification. In panels (B-l), xGAT1 signal is stained magenta, while xVGIutl 
expression is blue, e, eye; nt, neural tube; fb, forebrain; mb, midbrain; hb,hindbrain; sc, 
spinal cord; so, somite. Dorsal side of the embryo is always at the top of the pictures.
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Histological sections reveal groups of neurons expressing both xGAT1 and 
xVGIutl mRNA in the medial-ventral region of the forebrain (Fig. 3B,C), midbrain (Fig. 
3D,E), and hindbrain (Fig. 3F-G). Co-localization of expression patterns is also present 
in the ventral-lateral area of the spinal cord (Fig. 3H,I).
RLDx distribution and comparison with existing fate maps
In order to construct a fate map of the 32-cell stage Xenopus embryo, each 
blastomere (Fig. 4) was injected with the fluorescent tracer molecule, RLDx. These 
embryos were allowed to develop to hatching stage, and the pattern of RLDx distribution 
examined (Fig. 5). Fluorescence patterns in the lens, muscle, notochord and gut were 
routinely compared with previously published fate maps as a positive procedural control 
(Moody, 1987).
In order to analyze the RLDx distribution in more detail, the CNS of each embryo 
was closely examined along both the dorsal-ventral axis and anterior-posterior axis. For 
data tabulation, the CNS was divided into forebrain (prosencephalon), midbrain 
(mesencephalon), hindbrain (rhombencephalon) and spinal cord along the anterior- 
posterior axis. Three separate regions in the CNS along the dorsal-ventral axis were 
observed for RLDx fluorescence: dorsal, lateral and ventral.
The major progenitors of the forebrain, midbrain and hindbrain are blastomeres 
D1.1.1, D1.1.2, D1.2.1 and D1.2.2. The cells derived from D1.1.1 and D1.1.2 are found 
throughout the forebrain, midbrain and hindbrain, while D1.2.1 and D1.2.2 contribute 
preferentially to dorsal regions. D2.2.2, V1.2.1 and V1.2.2 occasionally give rise to the 
dorsal parts of the forebrain, midbrain and hindbrain (see Appendix A, Table 3).
Lineage analysis ofxG ATI- and xVGIutl-positive neurons
To investigate the origins of GABAergic and glutamatergic neurons in the 32-cell
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Figure 4. Schematic of Xenopus blastomere nomenclature. Each blastomere of the 
32-cell-stage Xenopus laevis embryo is labeled according to the convention of Jacobson 
and Hirose (1981). Cells beginning with V denote ventral blastomeres, while those 






Figure 5. Analysis of blastomere lineage using RLDx injected embryos. Each 
panel shows a representative stage 35 whole mount embryo demonstrating the 
localization of RLDx fluorescence after its injection into each blastomere, as indicated, at 
the 32-cell stage. (A) D1.1.1, (B) D1.1.2, (C) D1.2.1, (D) D1.2.2, (E) D2.1.1, (F) D2.1.2, 
(G) D2.2.1, (H) D2.2.2, (I) V1.1.1, (J) V1.1.2, (K) V1.2.1, (L) V1.2.2, (M) V2.1.1, (N) 
V2.1.2, (O) V2.2.1, (P) V2.2.2. Dorsal side of the embryo is always at the top of the 
pictures, and anterior is always at the left side of the pictures.
D (D1.2.2)
O (V2.2.1) P (V2.2.2)
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stage embryos, co-localization of the in situ signal with RLDx was observed.
a. Co-localization of RLDx and xGA T1 mRNA
Forebrain: Generally, xGAT1-expressing neurons in the lateral and ventral 
region of the forebrain descend from the dorsal blastomeres D1.1.2 and D1.1.1, 
although D1.1.1 contributes a smaller proportion of cells to ventral regions. Blastomere 
D1.2.1 contributes to xGAT1 neurons in only half of the embryos examined, while 20% 
of blastomere D1.2.2 gives rise to xGAT1 neurons in this region.
Midbrain: The major contributors of xGA77-expressing neurons in the midbrain 
are the dorsal blastomeres D1.1.1 and D1.1.2 (Fig.6 A-D). Other dorsal blastomeres 
give rise to xGAT1 neurons in the midbrain region at lower frequencies: 50% of D1.2.1, 
40% of D1.2.2, 40% of D2.2.2, 40% of V1.2.1, and 20% of D2.1.2-injected blastomeres 
give rise to neurons expressing xGAT1.
Hindbrain: A majority of xGAT1 neurons in the hindbrain originate from the 
dorsal blastomeres D1.1.1, D1.1.2, D1.2.1, and D1.2.2. The ventral blastomere V1.2.1 
contributes to xGAT1 neurons in the lateral hindbrain, while only 20% of D2.1.2, 40% of 
D2.2.2, and 20% of V2.2.2-injected blastomeres give rise to xGAT1-expressing cells in 
this region.
Spinal cord: In the spinal cord, dorsal blastomeres D1.1.1, D1.1.2, D1.2.1 and 
D1.2.2 give rise to xGAT1 neurons in both lateral and ventral regions, while ventral 
blastomere V1.2.1 contributes only in the lateral region. A few cells derived from 
blastomeres D2.1.2, D2.2.1, D2.2.2, V1.2.2, and V2.2.2 co-localize with xGAT1 
expression in the spinal cord.
In summary, GABAergic neurons are mostly derived from the animal dorsal 
blastomere, and among these blastomere, D1.1.1 and D1.1.2 produce more GABAergic
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Figure 6. Analysis of co-localization of RLDx with xGAT1 and xVGIutl RNA 
expression in the midbrain region. Representative sections of an embryo injected in 
blastomere D1.1.2 showing the co-localization of RLDx with xGAT1 (A-D) or xVGIutl (E- 
H) in situ hybridization signals. (A,E) Bright field images of xGAT1 or xVGIutl 
expression with arrows denoting ISH staining in the brain region. (B,F) RLDx 
fluorescence distribution in the same region. (C,G) The merged image reveals the 
overlap of ISH signal with RLDx fluorescence. (D,H) Merged false-color image showing 
ISH signal (blue), RLDx-labeled cells (red), and co-localization of xGAT1 or xVGIutl with 
RLDx fluorescence (yellow).
oX
















Figure 7. Summary of fate mapping of the 32-cell stage Xenopus embryo. The
diagram shows a representation of the average percentage of (A) GABAergic or (B) 
glutamatergic neurons in a specified region that are derived from the given blastomere. 
An average score for each structure derived from a given blastomere was calculated 
based on the data contained in Tables 2 and 3 in Appendix A. See the legends of 
Tables 2, 3, and 4 for a detailed description of this method. A red abbreviation indicates 
that >50% of the GABAergic or glutamatergic neurons in that region are derived from the 
given blastomere. Blue letters indicate that 25-50% of the GABAergic or glutamatergic 
neurons in that region are derived from the given blastomere. Likewise, black letters 
indicate that 0-25% of the GABAergic or glutamatergic neurons in that region are derived 
from the given blastomere. CG, cranial ganglia: V (trigeminal), VII (facialis), VIII 
(acousticus), IX (glossopharyngeal); FB, forebrain; HB, hindbrain; MB, midbrain; OL, 
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neurons than the other two blastomeres (Fig. 7 A). A number of other blastomeres are 
capable of generating a smaller proportion of xGAT1 neurons.
b. Co-localization of RLDx and xVGIutl mRNA
Forebrain: D1.1.1, D1.1.2, D1.2.1 and D1.2.2 give rise to the majority of 
xVGlut7-positive neurons in the dorsal, lateral and ventral regions of forebrain. Only 
70% of embryos examined give rise to xVGIutl-positive neurons in the forebrain, while 
40% of V1.2.1 and 20% of V1.2.2 injected blastomeres give rise to xVGIut1-expressing 
cells in the dorsal forebrain.
Midbrain: The major progenitors of xVGIutl neurons in the midbrain are D1.1.1 
and D1.1.2 (Fig. 6E-H), as is also the case for xGA77-expressing neurons in this region. 
In the embryos examined where D1.2.1 and D1.2.2 contributed fluorescence to the 
lateral forebrain, the amount of co-localization with xVGIutl expression was less than 
that of blastomeres D1.1.1 and D1.1.2. 17% of D2.2.2 and 20% ofV1.2.2 injected 
blastomeres give rise to xVGIutl-expressing cells in the lateral region of midbrain.
Hindbrain: A majority of x\/G/tvf7-expressing cells derived from D1.1.1, D1.1.2,
D1.2.1, D1.2.2 were found in the lateral forebrain, while approximately half of the 
embryos examined for each of these blastomeres also gave rise to some xVGIutl 
neurons in the ventral hindbrain. In general, the descendants of D2.2.2 are found in the 
dorsal and lateral hindbrain, with a portion of these cells expressing xVGIutl.
Spinal cord: All of the blastomeres, with the exceptions of D2.1.1, V1.1.1, V2.1.1 
and V2.2.1, generate varying numbers of xVGIutl neurons. However, the major 
progenitors of cells expressing xVGIutl in the spinal cord are D1.1.1, D1.1.2, D1.2.1, 
D1.2.2, D2.2.2, V1.2.2 and V2.2.2.
These results demonstrate that the blastomeres giving rise to xVGlutl- 
expressing neurons in the CNS are similar to the progenitors of xGATI-positive neurons.
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We can also conclude that some blastomeres give rise to xVGIut1-expressing neurons in 
distinct regions of the CNS.
Olfactory placodes: The major progenitors of xl/G/afl-expressing neurons in 
the olfactory placodes are D1.1.1 and D1.2.1. Approximately half of the D1.1.2, D1.2.2, 
and V1.2.1-injected embryos also give rise to xVGIutl neurons in the olfactory placodes. 
In addition, there were few numbers of xVG/uff-positive neurons arising from blastomere 
V1.2.2.
Pineal gland: The majority of xVGlutt-expressing neurons in the pineal gland 
are derived from blastomeres D1.1.1, D1.2.1, and V1.2.1. Sixty percent of the embryos 
with blastomeres D1.1.2 and D1.2.2 labeled generate xVGIutl neurons in the pineal 
gland. In addition, there were few numbers of xVGIutl-positive neurons arising from 
blastomere V1.2.2.
Cranial ganglion (V, VII, VIII, IX): All the blastomeres except V1.1.2, V2.1.1, 
V2.1.2 and V2.2.1 contribute at least some cells to cranial ganglia V, VII, VIII and IX. 
However, the major progenitors of xt/G/iv/f-expressing neurons are blastomeres D1.1.1, 
D1.1.2, D1.2.1, D1.2.2 and V1.2.1. In most cases, D2.2.2, V1.1.1 and V1.2.2 will give 
rise to xVGIutl neurons in the cranial ganglion, and a small number are from D2.1.1, 
D2.1.2, D2.2.1 and V2.2.2.
In summary, glutamatergic neurons in the central nervous system are mainly 
derived from the animal dorsal blastomeres, D1.1.1 being a major contributor. There are 
some differences between the origins of the different regions of the CNS. More 
glutamatergic neurons in the forebrain and midbrain are derived from the animal midline 
blastomeres D1.1.1 and D1.1.2 than blastomeres D1.2.1 and D1.2.2, while there are no 
obvious differences between the contribution of these four animal dorsal blastomeres to 
glutamatergic neurons in the hindbrain and spinal cord. When compared with
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glutamatergic neurons in the CNS, the cranial ganglia in the peripheral nervous system 
originate from a broader range of blastomeres (Fig. 7B).
Cell Culture Experiments
While lineage may play a role in determining GABAergic and glutamatergic 
neural phenotypes, it is also clear that cell-cell interactions are likely to be essential for 
the determination of these two kinds of neurons. We employed an in vitro cell culture 
approach to test what neurotransmitter phenotype presumptive neural cells derived from 
embryos at different developmental stages would give rise to in the absence of further 
tissue interactions. Specifically, we wished to test whether GABAergic neurons serve as 
a default neural phenotype as proposed in the literature (Carpenter et al., 1999; Jain 
et al., 2003).
Immunocytochemistry was carried out on cell cultures to detect neurons using 
GABA as a neurotransmitter. Likewise, xGAT1 and xVGIutl were used as markers of 
GABAergic and glutamatergic neurons for in situ hybridization procedures. Ninety-six 
cultures derived from the presumptive neural tissue at various developmental stages 
were assayed. Forty-four cultures were used for immunocytochemistry and 52 of them 
in ISH procedures.
General Characteristics of Cultured Cells
Differentiated cell types, including epidermal cells, muscle cells, and neurons, 
appeared in culture even when the presumptive neural tissue was taken from a mid- 
gastrula stage embryo (Fig. 8). Neurons included simple unipolar, bipolar and more
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Figure 8. Representative cell types found in Xenopus primary cell culture. (A) Two
neurons, (B) muscle cells, (C) muscle cell and the arrow indicates an undifferentiated 
cell, (D) neuron (bottom left) and a cell of unknown type (right).
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complex multipolar shapes (Fig. 8A, D). Muscle cells were identified by their spindle- 
shaped bodies and striations (Fig. 8B, C). Morphologically undifferentiated cells were 
present as spheres (Fig. 8C, arrow). Cellular morphologies described by (Banker and 
Goslin, 1991) were used as standards to identify muscle, fibroblast, melanocyte, and 
neural cells.
At all the stages (St. 10-22) examined, the dominant cell type was undifferentiated, 
which constitutes 70-98% of the total cell numbers. This percentage, however, 
decreased with the age of embryos from which a culture was derived. Neurons make up 
roughly 0-18% of the total cells present at various stages, with muscle and other types 
constituting the remaining cells. The total number and percentage of neurons (as a 
proportion of total cells) increases steadily from late gastrula stages (Table 1).
GABA Immunocytochemistry
A summary of the cell counts obtained from immunocytochemistry using an anti- 
GABA antibody is shown in Table 1. Somewhat surprisingly, the percentage of GABA- 
positive cells as a proportion of total cells is highest in cultures of presumptive neural 
tissue removed at stage 10 (Fig. 9). This percentage then decreases to a low point of 
9% at stage 12 and remains constant throughout later stages. The percentage of 
morphologically distinguishable neurons staining positively for GABA increases from 6.7 
to 34.8% of total neurons over the stages examined. Representative photographs of the 
results obtained from immunocytochemistry are shown in Fig. 10.
ISH of XGAT1
To detect xGAT1 mRNA expression, in situ hybridization was performed on a 
total of 29 cell cultures (Table 1, Fig. 12 D-F). The ISH data are consistent with the 
results of GABA immunocytochemistry.
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Figure 9. Summary of GABA expression in Xenopus primary cell culture. Lines 
indicate the average percentage of undifferentiated cells (dark), neurons (red), and 
GABA-positive cells (turquoise) from early gastrula stages to tailbud stages as a 
proportion of the total number of cells. * GABA-positive neurons (yellow) are depicted 
as a percentage of the total number of neurons.
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Table 1. Summary of Xenopus primary cell culture experiments. Values shown are 
the percentages of the total number of cells counted in cultures derived from the 
presumptive neural tissue of each developmental stage examined. Note that the final 
column for each experiment includes both neurons and undifferentiated cells that were 
positive for marker expression.
48
Immunocytochemistry
Stages M orphologically O ther Muscle Neurons GABA- GABA-
Undifferentiated cells cells positive positive
cells neurons cells
St. 10 100 0 0 0 0 23.3
St. 11 99.7 0.3 0 0 0 11.3
St. 12 96.3 2.4 1.1 0.25 6.7 9.2
St. 14 87.2 6 6.3 3 30.5 10.3
St. 16 86.25 4.7 4.3 4.7 30.8 14.5
St. 18 86.6 3.3 2.2 9 33.4 14.9
St. 20 76.7 12.2 1.3 14.6 34.8 12.5
St. 22 70 8.5 3.8 17.4 34.6 14.3
XGAT1 ISH
Stages Morphologically O ther Muscle Neurons GABA- GABA-
Undifferentiated cells cells positive positive
cells neurons cells
St. 10 100 0 0 0 0 24.3
St. 11 99.6 0 0.13 0 0 13.6
St. 12 94 4.2 1.2 0.7 12 10.8
St. 14 87.8 3.9 5.2 2.8 31.9 9.5
St. 16 86 8.8 1.1 5.7 34.1 13.9
St. 18 77.9 9.7 4.9 7.3 41.8 14.2
St. 20 72.8 5.7 4.3 17 28.9 12.3
St. 22 74.6 5.8 3.1 16.5 33.6 14.9
xVG Iutl ISH
Stages Morphologically O ther Muscle Neurons GLUT- GLUT-
Undifferentiated cells cells positive positive
cells neurons cells
St. 10 100 0 0 0 0 16.4
St. 11 99.1 0.6 0 0 0 10.8
St. 12 95.2 2.9 1.7 0.7 14.9 7.6
St. 14 86.7 1.4 9.3 2.5 21 9
St. 16 79.8 5.8 2.2 5.6 31.9 12.1
St. 18 85.5 3.8 0.9 9.7 36.9 16.2
St. 20 83.2 5.8 0.1 10.8 25.2 14
St. 22 72.9 6.8 7.2 13.1 32.1 13.3
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Figure 10. Representative examples of immunocytochemistry in Xenopus primary 
cell culture. (A) Representative neurons staining positively for GABA expression. (B) 
GABA-positive neuron adjacent to a negative undifferentiated cell. (C) GABA-positive 
undifferentiated cell adjacent to two undifferentiated cells negative for GABA expression. 
(D) A muscle cell staining positively for muscle actin used as a positive procedural 
control. Arrows indicate GABA specific signal.
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The percentage of xGATI-positive cells as a proportion of total cells was highest 
at the early gastrula stage and then decreased to a low of 9.5% at late gastrula stage, a 
trend which is consistent with the GABA immunocytochemistry experiments (Fig. 11). 
xGAT1 RNA expression was detected in cultures dissociated as early as gastrula stages, 
and the number of xGAT1-expressing neurons as a proportion of total number of 
neurons increased from 12% to 41.8% over the developmental stages examined.
ISH of xVGLutl
Twenty-three cultures were examined for the expression of the xVGIutl mRNA 
using ISH (Table 1, Fig. 12A,B). The percentage of xVGIutl-positive cells as a 
proportion of total cells was highest at the early gastrula stage and then decreased to a 
low of 7.6% at mid-gastrula stage; this trend is consistent with the trends of GABA- 
positive cells and xGAT1-positive cells (Fig. 13). xVGIutl mRNA was expressed in cells 
dissociated as early as gastrula stages, and the number of xVGlut7-expressing neurons 
as a proportion of total number of neurons increased from 14.9% to 36.9% over the 
stages examined.
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Figure 11. Summary of xGAT1 mRNA expression in Xenopus primary cell culture.
Lines indicate the average percentage of undifferentiated cells (dark), neurons (red), and 
xGAT1-positive cells (turquoise) from early gastrula stages to tailbud stages as a 
proportion of the total cell number. * xGAT1-positive neurons (yellow) are depicted as a 

























































































Figure 12. Representative examples of in situ hybridization in Xenopus primary 
cell cultures. In situ hybridization was performed using an antisense RNA probe for 
xVGIutl (A,B), muscle actin (C), or xGAT1 (D-F). (A) A xVGIutl-positive neuron adjacent 
to a non-expressing neuron. (B) Positively stained undifferentiated cell adjacent to an 
xVGIutl-negative undifferentiated cell. (C) Representative muscle cell stained positive 
for muscle actin expression and used as a positive procedural control. (D) xGA77- 
positive neuron adjacent to two non-expressing neurons. (E) A single neuron 




Figure 13. Summary of xVGIutl mRNA expression in Xenopus primary cell culture.
Lines indicate the average percentage of undifferentiated cells (dark), neurons (red), and 
x\/G/uf 7-positive cells (turquoise) from early gastrula stages to tailbud stages as a 
proportion of the total number of cells. * xVGlut7-positive neurons (yellow) are depicted 



















































































The vertebrate CNS is composed of a wide variety of neuronal cell types, each 
essential for proper neural functioning. During neurulation, the cells become post-mitotic 
and differentiate into neurons, but how these different phenotypes are established during 
development is not well understood for most neurotransmitter phenotypes, particularly 
for the GABAergic and glutamatergic phenotypes.
Two basic mechanisms of fate determination have been proposed: cell lineage 
and cellular interactions. In the present study, we first tried to determine whether early 
lineage plays dominant role in GABAergic and glutamatergic fate determination and, 
secondly, we attempted to assess the state of specification of presumptive cells at 
various stages of neural development.
GABAergic Neurons Arise From Animal Dorsal Blastomeres, Whereas 
Glutamatergic Neurons Arise From a Broader Range of Blastomeres
Given that earlier literature suggested that lineage plays a pivotal role in cell fate 
determination within the retina (Huang and Moody, 1993), we designed an experiment to 
test if this is also the case for the determination of GABAergic and glutamatergic 
neurons within the Xenopus CNS.
The RLDx fluorescence patterns we obtained from different blastomeres are 
consistent with the previous fate maps (Dale and Slack, 1987; Moody, 1987) that served 
as a positive control for our results. The major progenitors of the CNS are D1.1.1,
D1.1.2, D1.2.1, D1.2.2, D2.2.2, V1.2.1 andV1.2.2. However, our studies went beyond 
previous analyses and specifically attempted to identify the progenitors of GABAergic 
and glutamatergic neurons. The major progenitors for GABAergic and glutamatergic 
neurons are animal-dorsal blastomeres D1.1.1, D1.1.2, D1.2.1 andD1.2.2. A number of 
ventral blastomeres also give rise to the glutamatergic neurons in the peripheral nervous 
system. This result is consistent with the fate map Moody’s, although those investigators
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described the origins of the cranial nerves based on their positions without using specific 
marker (Moody, 1987). The mechanism of why cranial nerves arise from a broad range 
of blastomeres in Xenopus is not well known. However, some researchers using 
ascidian tadpole larvae as model system showed that the origin of peripheral nervous 
system is different from that of the central nervous system. They also found that signals 
from vegetal blastomeres are involved in the development of ascidian peripheral nervous 
system from anterior and posterior animal blastomeres. It may suggest that there are 
distinct mechanisms that involved in the specification of peripheral nervous system and 
central nervous system during early development (Ohtsuka et al., 2001).
Lineage Does Not Play an Essential Role in GABAergic and Glutamatergic 
Phenotype Determination
There are two general mechanisms by which lineage may have effect on 
phenotype determination. First, a progenitor may become committed to produce 
descendants of only one type (Huang and Moody, 1992). Secondly, lineage may also 
play a role by imparting a bias for a subsequent fate restriction.
However, from our observations, we can conclude that the first possibility does 
not apply for the blastomeres of the 32-cell stage Xenopus embryo; each blastomere 
can produce a wide range of cell types. Our data are consistent with clonal analyses in 
the retina (Holt et al., 1988; Wetts and Fraser, 1988), optic tectum (Galileo et al., 1990; 
Gray and Sanes, 1992) and spinal cord (Leber et al., 1990) that demonstrated a diverse 
array of cell phenotypes from single precursors. Thus, commitment must occur later in 
development in the presumptive neural plate, perhaps even at the early gastrula stage.
According to the second possibility, we would expect to see that the descendants 
of a single blastomere might give rise to more GABAergic neurons than glutamatergic 
neurons or vice versa. However, our experiments show that this is not generally the
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case. When a given blastomere gives rise to a region containing both glutamatergic and 
GABAergic neurons, both will generally be present in equal proportions. The only 
exception to this generalization is D1.1.1, which produced more glutamatergic neurons 
than GABAergic neurons in the ventral region of the brain and spinal cord (see Appendix 
A, Table3). This could indicate that, in certain instances, lineage provides a bias to 
produce a particular combination of GABAergic or glutamatergic descendants, although 
more experiments will be necessary to show statistical significance. Thus, it appears 
that early lineage does not have a significant influence on widespread neuronal type 
determination.
GABA and Glutamate May Serve as Default Neurotransmitters
It is clear from the present study that lineage does not play an essential role in 
determining GABAergic and glutamatergic phenotypes. Therefore, we postulated that 
cell-cell interactions serve as the primary determinative factor. Toward this end, we 
assessed the state of specification of GABAergic and glutamatergic phenotypes at 
various stages of development in a cell culture experiment. Isolating neural or 
presumptive neural cells from their normal environment and, hence, continuing cell-cell 
interaction, provides important information regarding the role of these interactions in 
neurotransmitter phenotype determination. In addition, this experiment was designed to 
test the hypothesis put forth in the literature that GABA serves as a default 
neurotransmitter phenotype.
There are several conclusions that can be drawn from our cell culture data. First, 
not surprisingly, the average number of undifferentiated cells decreases with the age of 
embryos. This is easily explained, given that cell-cell interactions are important for the 
differentiation of numerous different cell types; the longer cells are in contact with each 
other, more will become differentiated.
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Second, neurons appear in cultures even when the presumptive neural tissue is 
derived from early stage embryos. In addition, we demonstrate that cells isolated from 
Xenopus presumptive neural tissue could differentiate into GABAergic or glutamatergic 
neurons, even when the presumptive neural tissue is dissected at the mid-gastrula stage; 
this is consistent with earlier studies based on morphological criteria.
Third, it is possible that both GABAergic and glutamatergic neurons serve as 
default neural phenotypes, since the cells removed from the earliest stages show the 
highest percentages of these two types of neurons. These cells continue to differentiate 
in vitro into neurons containing GABA, or expressing xGAT1 or xVGlutl, without further 
interactions with neighboring tissues at early stages. That means that an intrinsic 
developmental program exists in each cell that instructs them to differentiate into 
GABAergic and glutamatergic neurons. This is not entirely consistent with other studies, 
which report that neurons predominantly adopt a GABA phenotype in culture. In those 
experiments, after isolation and expansion, human neural progenitor ceils will 
differentiate into GABAergic neurons in vitro. Carpenter et al. (1999) and Jain et al. 
(2003) have also demonstrated that GABA is the default pathway for neurons derived 
from expanded human neural precursor cells (hENPs). However, these investigators 
used growth factors (FGF and BDNF) in the cell cultures under investigation, which may 
have caused the GABAergic neurons to override glutamatergic neurons, so that 
GABAergic neurons would appear to be the default phenotype.
Moreover, both GABAergic and glutamatergic cells are present at the highest 
levels in cultures derived from the presumptive neural tissue at early gastrula stages. 
There is a decline of both neuronal types in the cultures originating from older 
presumptive neural tissue, followed by a gradual increase in the percentage of 
GABAergic and glutamatergic neurons in cultures derived from presumptive neural 
tissue of older embryos. This is consistent with the idea of cell-cell interactions leading
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to the development of different cell types. Thus, the morphologically undifferentiated 
cells that originally possess the potential to differentiate into GABAergic and 
glutamatergic neurons are gradually replaced by the specific cells types in vivo.
Future Direction
There are many questions that remain to be resolved, as well as new questions 
raised by these experiments. While early lineage does not play an essential role in 
determining GABAergic and glutamatergic neurons, it is possible that it plays a more 
crucial role later in development. Experiments in which a fluorescent tracer is injected 
into the cells of the presumptive neural plate at early gastrula or late gastrula stages 
would test this possibility. It would also be informative to determine if the GABA and 
glutamate neurotransmitters are co-expressed in early neuronal cells. The investigation 
of other neurotransmitters (e.g. serotonin, dopamine) using additional markers would 
also prove worthwhile.
Future experiments should aim to discern the molecular mechanisms governing 
GABAergic and glutamatergic determination. The determination of these two neural 
phenotypes may be regulated by a number of factors, including proneural genes, 
neurogenic genes, postmitotic selector genes, cell cycle, and/or growth factors. The 
genes expressed in the same regions with GABAergic or glutamatergic neurons can be 
regarded as candidate genes involved in the process. The functions of these intrinsic 
factors can be determined by blocking or up regulating their expression in developing 
embryos. Specifically, the genes necessary for specification of GABAergic and 
glutamatergic neurons can be examined by employing a morpholino-based loss-of- 
function approach. Conversely, the injection of candidate gene mRNA into the two-cell 
stage embryo can assess the effects of ectopic overexpression throughout the embryo.
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We can also test the role of specific cell-cell signaling interactions in the 
specification of the GABAergic and glutamatergic neurotransmitter phenotypes. 
Candidate signaling include Fgf2, which is essential for the proliferation and 
differentiation of neural stem cells (Korada et al., 2002), and other molecules such as 
Shh and BMPs that aid in specifying discrete progenitor domains via concentration 
gradients. It is worth testing if these signaling pathways are able to direct neural 
progenitor cells in culture to adopt a GABAergic or glutamatergic fate. Specifically, cell 
cultures can be incubated with these growth factors at different concentrations, and used 
for immunocytochemistry and in situ hybridization to detect if there are any changes in 
GABAergic and glutamatergic cell numbers.
Cell cycle may also influence the determination of GABAergic and glutamatergic 
neural phenotypes. Recent studies suggested that the regulation of cell fate 
determination may be related to the timing of cell cycle exist, the orientation of the 
mitotic spindle during the last cell division (Malicki, 2004). There are a number of genes 
have been discovered that regulate both the cell cycle as well as specific cell fates 
(Kabos et al., 2002; Ohnuma et al., 2002). For example, XIC1 and cyclin A2/cdk2 have 
been identified that specifically affect cell cycle control within the nervous system 
(Carruthers et al., 2003; Vernon and Philpott, 2003).
The role of the cell cycle in phenotype determination can be examined by 
overexpressing key cell cycle regulators to determine whether GABAergic and 
glutamatergic neurons employ these cell cycle regulators in their specification pathways. 
The role of cell cycle can also be tested by stopping cell division by treating the embryos 
with DNA synthesis inhibitors, hydroxyurea and aphidicolin, at early stages. The 
embryos can be examined for whether there are subtle differences in the expression 
patterns of GABAergic and glutamatergic neurons following cell cycle perturbation at the 
hatching stage.
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The present study demonstrates that lineage does not play an essential role in 
the determination of GABAergic and glutamatergic neural phenotypes at early cleavage 
stages. Instead cell-cell interactions serve as a major determinative factor that regulates 
the adoption of these two phenotypes. For the future, the identification of the intrinsic 
and cell-cell signaling factors involved will be essential in understanding the mechanism 
governing the process of GABAergic and glutamatergic fate determination in the 
vertebrate central nervous system.
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APPENDIX A
Fate Map Primary Data
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Table 2. Approximate percentages of RLDx-labeled cells and co-localization with 
ISH signals within each organ system. Each row represents the data obtained from 
an embryo for the given blastomere and neurotransmitter phenotype. Abbreviations at 
the head of each column represent the regions analyzed: OL, olfactory placodes; PG, 
pineal gland; CG, cranial ganglia: V (trigeminal), VII (facialis), VIII (acousticus), IX 
(glossopharyngeal); RET, retina; LENS, eye lens; NC, notochord. Symbols to the left of 
each slash indicate the approximate percentage of the region labeled by RLDx using the 
notation system described in Table 2. Symbols to the right of each slash indicate the 
approximate percentage of the region in which RLDx fluorescence was co-localized with 
xGAT1 or xVGIutl expression. The locations of labeled or co-localized cells within a 
particular region are designated as follows: d, dorsal; i, intermediate; v, ventral; B, 
bilateral. Locations of labeled or co-localized cells along the AP axis of the retina are 
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Table 3. Approximate percentages of RLDx-labeled cells and co-localization with 
ISH signals within the CNS. Each row represents the data obtained from an embryo for 
the given blastomere and neurotransmitter phenotype. Abbreviations at the head of 
each column represent the organs analyzed: FB, forebrain; MB, midbrain; HB, hindbrain; 
SC, spinal cord. The symbols to the left of each slash indicate the approximate 
percentage of the organ labeled by RLDx using the notation system described below. 
Symbols to the right of each slash indicate the approximate percentage of the organ in 
which RLDx fluorescence was co-localized with xGAT1 or xVGIutl expression. The 
locations of labeled or co-localized cells within a particular region of an organ were 
designated as follows: d, dorsal; i, intermediate; v, ventral; B, bilateral. Percentages of 
labeled or co-localized cells within a particular organ region are notated as follows: ++, 
>50% of the organ contained labeled or co-localized cells; +, 25-50% of the organ 
contained labeled or co-localized cells; *, 0-25% of the organ contained labeled or co­
localized cells; -, no labeled or co-localized cells; ?, tissue section missing so that the 





> £ *> •>  £  *>  >  
+
+ +  *
+ * * +  * X  ^
> > > > > > >
+
* .±. *_  ±
+ + 





>  >  









+ + * >  >  >
+ + + + 
> >  >  >
+ ±
+  +  * * 
H  U  T3 D
+
+> >  >  >  >
+
- * * *  + * + +  +  + * 








+  + 
T3 T3
>  >














>  > * >























+ + +  +  * 









+  *_  *_
*  *  *  
-o  "0 *0






+ * + 
> > >








+ + + +  + + + *  + + T 3 T 3 T D -0 ’a _0 X 3 T 3 T 3 T 3
CD + ++ « + * + « + + + > *+ + + + + > > > > > > > > >> > > > > + + ++ + + + + .+ + ++ + + + + ’ ‘ ‘ ‘+ ++ + + * + + + + +T3 T3 ■a T3 T3 ■a TD "D T3
+ + ++ + + + + « + + + ¥> > > > > > > > > >
+ +
++!/ + + + * *_ + + + * + +5—'■— :—
+ + ++ + + + + * + + + + + *> > > > > > > > > > > >
+ +
++! + + ± i+B + + + +_ + + _+ +
+ + + ++ + + + * + + + + +■a ■o ■o ■o T3 T3 T3 T3 T3 T3
£ £
+  *
+  *  >  >













+ + + +
+ CD
+ + + + + +
T3 T3 ■o ■O TD T3
O x -  CM CO 
2? I— H  H  H  .Q <  <  <  <









H H h  < < <
+ +
+ + + * 




* + -a to
*  •— .z. *
+
+ + "O T3
CO
CD + +  CD
■n +  + + +
> > > > >
+ + + + + + + +
+ +
+ + + + + + + + + +
TJ ■O •D •a T 3 ■a T3 T 3 "O ■a
O T_ CN CO Nj- LO CD r^- CO CD
T— h - H 1 - h- 1— H H h - 1 -
1 - 3 3 3 3 3 3 3 3 3
< _ J _ i _ i — I _ i _ i _ i _ i _ i




•> £  
CD 
+ ±
* + +> + +^  >  >
+ + 







* + + 
> >  >
CD
+>
+ + + ++ + + + + + +
+ +
* * * + * +  +  +  + +  • U ' 0 ‘0 T 3 T 3 " 0 T 3 " 0 ‘a " 0
^ - C N c O ' ^ c o t D N c o a j r !
h h h h h h h h h f< < < < < < < < < 5










I -  I -  
3 3








V” T - T— T - T - T“ T - T - T - V - T - T - T - -r - T~ T— r - T - - r - T - CNJ CNJ CNJ CNJ CNJ CNJ CNJ CNJ CNJ CNJ CNJ CNI
T-’ T— X- T— T— T— T— 1 - T— T - T— T— t- ;
*
T - T - ■r- T— T— T - T— T— T - x—















+ + + * 
> > > >
+ + + +
+ + +  +  






+  *  *  +  
n  'D  -O  73
x + +> > > X X■X
> > >






TD + + + + + + *^  x XTD XTDi 1 ' ‘ ~ ' ""
* + +
> > > + * •X x x X X
> > > > > > > >
x_ +  -X + + ■X + * + + + + + +  .+ + +
X + + + + + + + + + + + X + + +





+ + + +
+ + > >
+ +
* + > >
+ ±  ±
t  t




+ + + + +
+ + + + 
73 73 73 73
+ + > >
+ +
+>
+ + + +  +  +  
7 3  7 3  7 3  7 3  7 3  7 3
*> > >
x_ x_ + +
++ * * , + *
73 73 73 .1  73 73
+> +>
+ + + +









i  i  + l  ^
CD
t  + t  +> > > >
CQ.+ + + + + + x_ *_
>
+
f— i * •—
+ + + *
* + 
■a t d
+ + + + + 73 73 73 73 73 +  +  +  +  +  +  7 3  7 3  7 3  7 3  7 3  7 3 + x x x + + 7 3  7 3  7 3  7 3  7 3  7 3 + * + + + + 73 73 73 73 73 73 + + t d  - a + * TD TD
, CD +
i t t
+ ±  ±  +
+ * 
TD TD 73 P 73
f t
+ + + + +
+ + X + X X
TD TD TD TD TD 1 TD
CO M " VO CO N - CO CD)J- 1- 1 - 1 - I - \— 1-
3 3 3 3 3 3 3_l _i _ l _ l _ l







+ + + + + + 73 73 73 73 73 73
r -  CM CO ^  lO  0I— I— I— h— h- H— < < < < < <  
0 O  0 0 0 0
73 P 73
*_ x_ x_ + +
+ * + * + +73 73 73 73 73 73
x -  CM CO M - LO COI— H H I— h- I—D D D D D D I  I  I i  l  I0 0 0 0 0 0
+ x + * + *73 73 73 73 73 73 + + TD TD
r - C M C O M - U 3 ( O N O O ( 3 ) “I— I— I— I— I— I— h~ Y~ I— | < < < < < < < < < 5
0 0 0 0 0 0 0 0 0 ( 3
P  TD
+ +  
TD TD
T - CM H 1- 3  3
_ l _ J
CD CD
CM CM CM CM CM CM CM CM T - T T - T - T - T - T - T~ T - T - X - X - CM CM CM CM CM CM CM CM CM CM CM CM
■5— T- t— T - t- t—■ T~' CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM CM
T— ■t— T- T—! T—i t— T - T—^ ■V- T— X— r - ^—■ x—• X— X— X— X— X— X— X— X— X— X— X— X— X—Q Q Q Q Q □ Q Q Q a Q Q a Q a a Q Q Cl Q a Q D Q Q Q Q Q Q o Q Q
73
+ +> >
*  *  ±  ±  
■— •— +  +  +  





* .i. i  *_
+ *  *  *  *  +  +  +  
■ O ’D ' D ' D - D ' D D ' D
+ *  
TD TD




+ * * > > >
+ * * > > >
+ * * * * + + +  
■ O T J T J T O ' O ' O ' O - O
*_ + ■* *_ *— .t+ ++ ■ * * * *  +  +  +  
T D T D T D T D T D T D T D T D
+ *  
TD TD TD TD
+
TD
+ *  
TD TD
CO ^










* + + +  
TD TD TD TDTD TD
ID CO 
I -  I—
Z ) 3 i  i  i  i —i —;
O O O O O o
h -
I -
0 0  CD
h -  h -  
=) Z )
T -  CM CO ^  COI— I— h- \~< <  <  < <o o o o o
CN CO
h  H  H  
=5 ZD Z ) 
_ l  _ l  _ l
O O O
t -  CN CO ^  COI— I— I— I— I—
<  <C <  <  <
O O O O O
T -  CN CO N -  i f i
I -  I -  I -  I -  H
=> ZD ZD ZD ZD I  I  I  I  I
O O O O O
r -  CM c o  I— I— I— I— < < < < o o o o
CM CM CM CM CM CM CM CM t- T—■ T - 1 - T - T— T - t -; CM CM CM CM CM CM CM CM CM CM ■<- ■<-
CM CM CM CM CM CM CM CM T— ^— T—■ T— T - T— T - v - t- ■*- t— T“ T— T— ■*- X " CM CM CM CM




i +  +
Y  73 73
* + > >
+ + + +
*_ ?L_ *_
*;o *;0 *T3 *
+ + + + + 
73 73 73 73 73




LO CO I- h- <  < 
O O
s— CN CO N- LO
h— I— f— I— I—
D D D D D I  l  l  l  l
O O O O O
r — cm ro ^  inI— I— I— I— I—< < <  < <O O O O O
CM CO LO coI- I- H f- I- I-
D D D D D D l  l  l  l  l  lo o o o o o
t— CN CO N" LOI- I- H H H< < < < <O O O O O
T- CN I- I- 
Z) ZD
_ l  _ lo o
CN CN 
CN c\ia  a
CN CN CN CN CM
CN csi CN csi csjQ Q Q Q a
CN CN CN CN CN 
CN csi C \i CN CN 
CN CN CN CN CsiQ Q Q Q Q
CN CN CN CN CN CN
csi csi csi csi csi csj
csi csj csi csi csi csi





















X  X  X  X
i +■ +■ "+
T  X  X  X  X
* _  * _  +  
+■+■"+
+  +  +  *  +  
X  -O  X  X  X
> >
+  *  +  *  *  
X  X  X  >  >
* + + * + 
x  x  x  x  x
XS x> X+■
+ + + * + X  X  X  X  X
+ + + + + 












CO M " LO CM CO ^  LOI— I— I— I— 
3 3 3 3<! <^  <!
O O O O O O O O
■r- CM CO LOh h h l - l -  <  <  < <  < O O O O O
T - CM CO TJ- LO
I -  t -  I -  I -  h -
3 3 3 3 3
_J 3  _1 _J _1
O O O O O
T -  CM CO M - SOI— I— I— I— I—< <  <  <  <O O O O O
T— CM CO ^  LO h h h h h  
3 3 3 3 33  3  3  3  3O O O O O
H<O
CM CM CM CM CM CM CM CM
> > >  > > > > >
CM CM CM CM CM 
> > > > >
CM CM CM CM CM 
> >  > > >
CM CM CM CM CM 
CM CM Csi CM CM
CM CM CM CM CM 
Csi Csi CM CM CM
> > > > >  > > > > > CM>
76
■Q X> "D
TJ iir~ 5~ 
T 3  XJ X3 r_
+ *
+ + *
■D H  T3 L
+TO
CN CO
< ^  
CD CD
t-  CM COI— f— H 
Z) Z) Z I  I  I
CD CD CD
t-  CM CO
«: <  <: 
cd cd cd
t-  CM COh h h  
Z) Z) z>
_ l  _ J  _ 1
CD CD CD
t -  CM COI- I- I- 
<  <  <  
CD CD CD
r -  CM COI— 1— I— 
ZD ZD ZD  I  I  I
CD CD CD
V -  CN CO ^  toI— I— H H H< < < < <




CN CN > >
CN CN CN > >  >
CN CN CN
CN CN CN > >  >
CN CN CN
CN CN CN > > >
CN CN CN 
C\i CN CN > > >
CN CN CN 
cn  csi csi 
> > >
CM CM CM CM CN 
Csi csi CN CN CN 





















































Table 4. Calculations of the average percentage of GABAergic or glutamatergic 
neurons in a specified region that are derived from the given blastomere. Data 
from Tables 2 and 3 were averaged using the following equation:
[(3 x (No. of ++ embryos)) + (2 x (No. of + embryos)) + (1 x (No. of * embryos))] / 
total number of embryos for a given blastomere)
Thus, an average score of 2-3 indicates that >50% of the GABAergic or glutamatergic 
neurons in that region are derived from the given blastomere. A score of 1-2 indicates 
that 25-50% of the GABAergic or glutamatergic neurons in that region are derived from 
the given blastomere. Likewise, an average of 0-1 indicates that <25% of the 
GABAergic or glutamatergic neurons in that region are derived from the given 
blastomere. Abbreviations are as specified in the legend of Tables 2 and 3.
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APPENDIX B
Primary Cell Culture data
81
Table 5. Data table for primary cell cultures used in immunocytochemistry and 
ISH. Note that the final column for each experiment includes both neurons and 
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Cell Culture Technique for spinal neurons and muscle cells of X. laevis
(From Culturing Nerve Cells, 1991, 137-153: Tabti and Poo and protocols from Dr. Ida 
Chow courtesy of the Szaro lab with modifications)
Solutions:




4) M gS04 0.1 OOg
5) Hepes 1.192g
Bring all ingredients up to a 1 L volume with sdd H20. pH to 7.6. Autoclave. Add 1ml 
penicillin/streptomycin mix underneath the laminar flow hood.





Bring all ingredients up to a 200 ml volume with sdd H20. pH to 7.4. Add 200 pi 
penicillin/streptomycin mix and filter sterilize. (Do not autoclave!)
Culture Medium:
1) 100% HBS solution 400ml
2) Leibovitz L-15 media (from Gibco)600ml
Add 200 pi of penicillin/streptomycin to 1 L and filter sterilize.
Procedure:
Note: Preparation of cell cultures should be carried out in a sterile hood using rigorous 
sterile technique as bacterial contamination is detrimental to the cultures.
1) Acquire the fertilized embryos from a mated pair of X. laevis frogs (try to get 
around 30 to 40 viable embryos for each stage you want to culture)
2) Dejelly embryos in 1/10 MBS solution with 2g cysteine and 1g NaOH solution, 
(check dejelly protocol for further information)
3) Put dejellied embryos in 1/10 MBS.
*l find it very helpful to get the embryos at stage 2 or 3 (2 or 4 cell) since it easy to 
distinguish these stages and then allow them to develop to the desired stages.
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4) Wait until embryos develop to the desired stages. (You can use the refrigerators 
set at different temperatures taking into account that at 18°C, the embryos 
develop at ~ Vt. the rate of embryos kept at 22°C and at 16°C, the embryos 
develop at ~ 1/3 the rate of embryos kept at 22°C)
5) Place all tools (dishes, forceps, pipettes, glass needles and clay dishes) into the 
UV sterilized laminar flow hood. Micropipettes (1000 and 200 pi) need to be 
wiped down with 70% EtOH before going in the hood. Tip boxes also need to be 
wiped down. Sterilize with UV light for 20-30 minutes.
6 ) Place embryos in HBS soln. in 60 mm plastic culture dishes (Falcon).
Sterilization: Prepare 5 sterile 60 mm plastic culture dishes:
Dish 1: 70% EtOH
Dish 2-5: HBS solution
Place dishes in a row with the 70% EtOH being the first one. Place sterilization 
sieve device in the glass Petri dish with all the desired embryos and transfer all 
the embryos into the sieve. Then quickly dunk the embryos in the EtOH solution 
for % of a second and quickly rinse off the EtOH with the HBS solution in the 
second dish and repeat until you are in the fourth dish. Then transfer all embryos 
to the fifth dish of HBS solution.
7) Demembranate:
a) Use asceptic forceps to remove the vitelline membrane (make sure to keep 
forceps and pipettes in the asceptic box or under the hood during this process). 
Occasionally dip the forceps in the 70% EtOH solution dish to sterilize. If the 
membrane sticks to the forceps, use a Kimwipe to remove and sterilize the 
forceps with the EtOH.
8) Washing the demembranated embryos:
Wash the nude embryos by transferring them successively through one dish of 
sterile HBS solution. (Use asceptic plastic pipettes for each transfer)
9) Preparation for dissection:
a) Fill the clay dish with HBS solution
b) Make wells in clay with asceptic glass tool (made from glass pipette)
10) Dissection:
a) Move embryos into the wells making sure their dorsal sides are facing 
toward you.
b) Remove the dorsal nerve tissue and try separating the epithelial and 
mesodermal layers of the dorsal side from the nerve tissue with glass 
needles.
*To remove the mesodermal tissues at later stages, it is best to incubate the 
dissected tissues in Collagenase IV at a concentration of 1 mg/ml for 1 hour 
and this will allow for easier separation of the tissues from one another.
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11) Dissociation:
*Done in 60 mm culture dish
a) Put all explants into the CMF dissociation solution for 15 to 45 minutes 
depending on whether you used collagenase or what stage tissues were 
taken (later stages need more dissociation time and collagenase 
treatment needs less dissociation time)
b) Get the micropipette (100 or 200 pi) ready for dissociation of tissues.
12) Cell Plating:
*Done in 35 mm (Nunclon) culture dishes
a) Fill each culture dish with 1000 pi of culture medium using the 1000 pi 
pipette.
b) Move the dissociated tissues into culture with micropipette (100 or 200 pi) 
by drawing up about 70 pi of culture medium and placing the tip in the 
CMF dish and gently releasing some culture medium over the tissue and 
drawing the tip in the CMF dish and gently releasing some culture 
medium over the tissue and drawing it up the tip, aspirate to fully break up 
the tissue.
c) Plant one explant into a dish.
13) Allow 15 minutes for cells to settle and then place cultures into a sterile tight- 
sealing box with moistened tissues and without any disturbance. If allowing 
cultures to go more than 2 days, change the medium at the end of the second 
day.
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Immunocytochemistry of Cell Cultures
(From Culturing Nerve Cells with modifications)
Solutions: 





Bring up to 1 L and pH to 7.4
10% (w/v) Bovine Serum Albumin (BSA) in PBS solution:
a) BSA: 5g
Bring up to 50 ml with PBS in a Falcon tube and shake vigorously and leave on a 
nutator until all dissolved. Store at 4°C.
3% (w/v) BSA in PBS solution:
a) BSA: 1.5g
Bring up to 50 ml with PBS in a Falcon tube and shave vigorously and leave on a 
nutator until all dissolved. Store at 4°C.
*Any time serum is used, it should be done under the laminar flow hoods. One can be 
found in the main lab, room 301, and the other one is in the cell/embryo lab, room 316. 








d. 100%PTw (PTw: PBS + 0.1 % Tween-20)
Leave in each solution for 5 minutes.
(1 mL volume is sufficient for1.5" diameter plates)
2) Wash the plates 3 times in PBS for 5 minutes each. TBS can also be used for 
this and other PBS washes.
3) Block the plates in 10% BSA solution for 30 to 60 minutes. (*done under a 
laminar flow hood)
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4) Remove the blocking solution and incubate the cells with a primary antibody 
diluted in 3% BSA solution (*done under a laminar flow hood) at some 
determined concentration (generally 1:100 with monoclonal antibodies and 1:500 
with polyclonal antibodies) overnight at 4°C in a tight-sealing container.
Day 2:
1) Remove the primary antibody and rinse 4 times with PBS for 10 minutes each.
2) Dilute the secondary antibody in 3% BSA solution (*done under a laminar flow 
hood) at some given concentration (usually 1:1000 for an alkaline phosphatase 
conjugated antibody and 1:500 for fluorescein conjugated antibody)
3) Incubate overnight at 4°C in a tight-sealing container.
Day 3:
1) Remove the secondary antibody and wash the plates 4 times with PBS for 20 
minutes each (1 ml volume each time).
For the alkaline phosphatase conjugated antibody:
2) Prepare the alkaline phosphatase (AP) buffer:
For 50 ml of AP buffer without levamisole:
1) 5 ml of 1M Tris (pH 9.5)
2) 2.5 ml of 1M MgCI2
3) 1 ml of 5M NaCI
4) 5 ml of 1 % Tween-20 solution or 50 pi of Tween-20.
-- Bring up to 50mL with SDD water.
*The AP buffer without levamisole can be stored, and the magnesium hydroxide 
tends to precipitate over time, but a slightly misty precipitate does not affect the 
reaction. The AP buffer can be stored at 4°C for longer storage and to slow 
down precipitation of the magnesium hydroxide.
*Add fresh levamisole before the reaction as it inhibits endogenous phosphatase:
0.0048 g of levamisole for every 10 ml of AP buffer and 0.024g for every 50 ml of 
AP buffer.
3) Wash the plates 2 times with the AP buffer (first time without levamisole or both 
times with) for 15 minutes each. (1 ml volume each time)
4) Add 4.5 pi of NBT and 3.5 pi of BCIP for every ml of AP buffer needed to make 
the AP reaction mix (reaction mix must be made fresh each time). It is best to 
add NBT first and mix thoroughly before adding BCIP.
* This reaction mix is light-sensitive, so its container should be covered in foil.
5) Incubate the cells in the reaction mix until the signal develops which depends on 
the abundance of the target. Minimize exposure to light during incubation.
6) Prepare 1X MEMFA to stop the reaction:
1X MEMFA:
a) 37% Formaldehyde 1ml
b) 10X MEMFA 1ml
Bring up to 10 ml with sdd H20.
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7) Remove the reaction mix and rinse with PBS and then add the 1X MEMFA for 1 
hour.
8) Remove the 1X MEMFA and add PBS and store in tight-sealing container at 4°C. 
For the fluorescein conjugated antibody:
2) Wash the plates in sdd H20  for 1 minute.
3) Add the fluormont antibleaching solution and place a coverslip over the cells.
4) Store in a container in the dark.
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In Situ Hybridization on Cultured Cells
(From Anderson Lab ISH Protocols with slight modifications: 
http://www.rodentia.com/wmc/docs/Big_ln_Situ.html)
*A modification of the procedure for the whole-mounts taking into consideration less 
rigorous washing for cell cultures:
*Take into consideration that the signal generally develops much more slowly as 
compared to either sections or whole mounts.
Day 1:




d. 100%PTw (PTw: PBS + 0.1 % Tween-20)
Leave in each solution for 5 minutes.
2. Wash 3 times in DEPC-PBS at room temperature for 5 minutes each.
3. To 25 ml of 0.1 M triethanolamine (pH 8.0) add 62.5 pi of acetic anhydride and 
quickly mix until thoroughly dispersed.
4. Incubate cultures in this mixture for 10 minutes at room temperature.
5. Wash cultures in 1X SSC for 5 minutes at room temperatures.
6 . Permeabilize cultures with 0.2M HCL in DEPC-H2Ofor 10 minutes.
7. Wash twice in DEPC-PBS for 5 minutes each.
8 . Prehybridize for 6 hours at room temperature in hybridization buffer (This step 
can go overnight if time does not allow for it)
9. Remove the hybridization buffer and add the probe (diluted in the hybridization 
buffer from the stock solution of 300 pi by taking 100 pi of the stock solution and 
diluting it further to 1000 pi by adding 900 pi of hybridization buffer). *500 pi of 
solution should be sufficient for each dish.
10. Let hybridize overnight at 60°C (To prevent evaporation, incubate in a tight 
sealing container which contains towels soaked in 50% formamide and 5X SSC)
Day 2:
1. Rinse cultures in 0.2X SSC and then wash in 0.2X SSC at 60°C for 1 hour.
2. Adjust cultures to room temperature by allowing to sit for 5 minutes.
132
3. Rinse in 0.2X SSC.
4. Block cultures in 20% sheep serum in PBT (PBS + 0.1% Triton-X100) for at least 
1 hour at room temperature.
5. Incubate cultures with anti-digoxygenin or anti-fluorescein antibody (depending 
on what was incorporated in your probe) diluted to a final concentration of 
1:1000 in 20% sheep serum in PBT at 4°C overnight (or for 2 hours at room 
temperature although longer periods of incubation at lower temperatures are 
better)
Day 3:
2. Rinse 3 times in PBT.
3. Wash 4 times with PBT at room temperature for 15 minutes each.
4. Wash twice in Alkaline Phosphatase (AP) buffer at room temperature for 10 
minutes each. (The first time without levamisole and the second time with 
levamisole)
For 50 ml of AP buffer without levamisole:
1) 5 ml of 1M Tris (pH 9.5)
2) 2.5 ml of 1M MgCI2
3) 1 ml of 5M NaCI
4) 5 ml of 1% Tween-20 solution
*The AP buffer without levamisole can be stored, and the magnesium hydroxide 
tends to precipitate over time, but a slightly misty precipitate does not effect the 
reaction. The AP buffer can be stored at 4°C for longer storage.
*Add fresh levamisole before the reaction as it inhibits endogenous phosphatase:
0.0048 g of levamisole for every 10 ml of AP buffer and 0.024g for every 50 ml of 
AP buffer.
5. Incubate in AP reaction mix (AP reaction mix consists of 4.5 pi of NBT and 3.5 pi 
of BCIP for every ml of AP buffer) until signal develops. *Signal may take from 2
to 36 hours depending on the abundance of RNA and it may be necessary to add
fresh reaction mix after 12 hours.
6 . After signal develops, wash in PBT and fix in MEMFA for 1 hour and store in PBS 
at 4°C in a tight-sealing container.
Preparation of 1X MEMFA:
a) 37% Formaldehyde 1 ml
b) 10X MEMFA 1ml
Bring up to 10 ml with sdd H20.
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Double In Situ Hybridization
(From Kroll Lab ISH Protocols with slight modifications: 
http://molecool.wustl.edu/krolllab/)
Day 1. Embryos into Probe.
Preparation of samples:
Embryos are fixed in MEMFA for 1-2 hours, then stored at -20°C in 100% 
EtOH in 5 ml vials until use.
1. Rehydrate.
Transfer embryos into DEPC-treated vials; use plastic “transfer” pipets.
Make each solution, incubate embryos in each wash for 5 min (fill the vials) 
75% EtOH/ 25% H20 
50% EtOH/ 50% H20
25% EtOH/ 75% PTw (1X PBS+0.1% Tween-20)
3X 100% PTw
2. Proteinase K treatment.
Incubate embryos at room temperature in 1 ml of 10 ug/ml Proteinase K for 
about 30 minutes in nutator. (10 ul of 10 mg/ml proteinase K in 10 ml 100% 
PTw)
3. Rinse 2X 5 minutes in 0.1 M Triethanolamine (pH7-8).
Triethanolamine is generally kept as a 1M stock solution at 4°C. Make 
yourself an aliquot of 0.1 M Triethanolamine (5ml 1M stock + 45ml sddH20).
4. Acetic Anhydride treatment.
To rinsed embryos add 5 ml 0.1M triethanolamine and to that add 12.5ul 
acetic anhydride. Rock tubes on nutator and after 5 minutes add another 
12.5u! acetic anhydride. Rock 5 minutes on nutator.
5. Wash 2X 5 minutes in 5 ml PTw.
6. Refix in Paraformaldehyde.
Refix with 4% paraformaldehyde (4 ml PTw + 1 ml 20% paraformaldehyde) 
for 20 minutes. You may want to set the water bath to 60 °C. You will need 
it in step9.
7. Wash 3X 5 minutes in PTw.
8 . Remove all but approx. 1ml PTw and add 250 ul hybridization buffer.
Once embryos have settled through the dense buffer, remove all the buffer 
and replace with 500 ul hybridization buffer.
134
9. Place embryos at 60°C in a shaking waterbath. 10 minutes.
10. Prehybridization  
6 hours at 60°C.
Replace hybridization buffer with another 500 ul. Usually this is done for 6 hr, 
but can go overnight.
11. Hybridization.
Overnight (12-16 hours) at 60°C.
Replace solution in vials with both a digoxigenin-UTP and a fluorescein- 
UTP conjugated probe each for 500ul.
Probe solution: Take out 100 ul of proble solution that is in 300 ul of Hyb 
buffer. Add 900 ul of Hyb buffer to bring it up to 1 ml. If re-using a probe, 
skip this dilution step because the probe should already be diluted.
Day 2. Into First Antibody
1. REMOVE PROBE AND KEEP. When you remove probe be certain that 
embryos do not dry out, leave a little probe soln. if necessary. Probe can be 
recycled up to 2 times.
2. 10 minutes, 60°C
Replace probe with hybridization buffer.
3. Rinse 3X with 2X SSC, 20 minutes each, 60°C
(2XSSC = 10 mis 20XSSC + 90 mis dH20)
Move to room 305 for the next several steps to contain the RNase
4. Next wash in 2X SSC, with RNaseA 20 ug/ml, 1ml in each vial at 37°C for 
30 minutes. Use different gloves and plugged tips for all RNase work. Also, 
use aliquots of SSC stored in room 305 to avoid contaminating your 
solutions with Rnase. (This step is optional, but it is useful to increase the 
stringency o f hybridization)
5. Washes.
10 minutes (OMIT if no RNase used) in 2XSSC at room temp.
Rinse 2X 0.2X SSC 30 minutes each at 60°C 
(0.2XSSC = 1 ml 20XSSC + 99 mis dH20)
You may move back to room 301 at this point
6. Rinse 2X 10 minutes each in MAB at room temp.
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7. Blocking
1 hour, room temperature (fill the vials)
MAB(1X) + 2% Boehringer Mannheim Blocking (BMB) Reagent.
BMB is often kept as a 4% stock solution. In that case, use equal volumes 
of 4% BMB and MAB to make the 2% BMB solution for this and subsequent 
steps. However, it is critical that you check the concentration of the 
BMB stock before making this solution!
8. Antibody incubation.
Rock vertically overnight_at 4°C
Replace with the same solution containing a 1:2000 dilution of the 
antidigoxygenin-alkaline phosphatase antibody (after the first color reaction, 
you will use a 1:2000 dilution of the antifluorescein-alkaline phosphatase 
antibody). Make you sure you add the right antibody to the right vial.
If two probes-add only one antibody, using the antibody against the most 
broadly expressed probe which will be detected using BCIP alone as an 
alkaline phosphatase substrate.
Day 3. W ashes and chromogenic reaction
1. MAB washes.
Wash 5 X 60 minutes each
One can be overnight at 4°C if washes are begun Day 2.
2. Alkaline Phosphatase buffer washes and chromogenic reaction.
Rinse 2X 5 minutes each in alkaline phos. buffer
For 50ml Alkaline Phosphatase Buffer (make fresh)
Then replace solution with wash buffer containing chromogenic substrates: 
3.5 pi BCIP (50mg/ml stock) to each ml of AP buffer. Replace last wash with 
the
1 ml AP mixture, incubate at room temperature Allow color reaction to 
develop; 5 minutes-1day.
One day is probably a good intermediate time to use in initial studies with a 
new gene, but this depends upon many variables, e.g. abundance, 
background levels.
100mM Tris, pH 9.5 
50mM MgCb 
100mM NaCI
0.1% Tween 20 
2mM Levamisol
5ml 1M Tris, pH 9.5
2.5ml 1M MgCI2 
1ml 5M NaCI 
50ul Tween20
0.06g Levamisol
Dilute to 50ml with sddH20
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The embryos can be examined periodically by tipping the vial and placing 
under the dissecting microscope. Dr. Saha will watch your embryos for 
you and determine when to stop the color reaction, so be sure to coordinate 
with her as to when you will start the color reaction.
8. Stop chromogenic reaction:
Tranfer embryos into MAB + 10mM EDTA. Place in 65°C waterbath for 10 
min
9. Fix chromogenic reaction
Replace MAB + 10mM EDTA with 1X fresh MEMFA (1ml 10X MEMFA salts 
+ 1ml 37% Formaldehyde + 8ml sddH20). Keep in MEMFA overnight at 
4°C.
Day 4: Second antibody staining
Go back to Day 2, Step 4 and repeat blocking, antibody incubation, and 
washes and chromogenic reaction:
1. Blocking: 1 hour, room temperature (fill the vials)
MAB(1X) + 2% Boehringer Mannheim Blocking (BMB) Reagent.
2. Antibody incubation: Make you sure you add the right antibody to 
the right vial. Rock vertically overnight_at 4°C
Day 5: Washes and second chromogenic reaction
1. MAB washes.
Wash 5 X 60 minutes each
2. Alkaline Phosphatase buffer washes and chromogenic reaction.
Rinse 2X 5 minutes each in alkaline phos. buffer 
Reaction as before, but use a different colorimetric substrate for alkaline 
phosphatase reaction: Add 4.5 pi NBT and 3.5 pi BCIP in each ml of AP 
buffer. Incubate at room temperature allow color reaction to develop
3. Stop chromogenic reaction
Replace AP mixture with 1X fresh MEMFA (1ml 10X MEMFA salts + 1ml 
37% Formaldehyde + 8ml sddH20). Keep in MEMFA overnight at 4°C.
4. Rinse 5 minutes in 1X PBS
5. Store in 1X PBS at 4°C
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